Nonischemic cardiomyopathy

I9_NONISCHCARDMYOP_STRICT

dilated cardiomyopathy: Cardiomyopathy which is characterized by dilation and contractile dysfunction of the left and right ventricles. It may be idiopathic, or it may result from a myocardial infarction, myocardial infection, or alcohol abuse. It is a cause of congestive heart failure.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions not I9_IHD and not I9_HYPERTROCARDMYOP	453760
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I42.0, I50.1 Hospital discharge: ICD-9 — 4281 Cause of death: ICD-10 — I42.0, I50.1 Cause of death: ICD-9 — 4281 2 out of 7 registries used, show all original rules.	4828
4. Check minimum number of events None	4828
5. Include endpoints None	4828
6. Filter based on genotype QC (FinnGen only)	4374

Control definitions (FinnGen only)

Control conditions: not I9_IHD
and not I9_HYPERTROCARDMYOP

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	I9_NONISCHCARDMYOP_STRICT
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!I9_IHD&!I9_HYPERTROCARDMYOP
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!I9_IHD&!I9_HYPERTROCARDMYOP
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I420\|I501
HD_ICD_9	4281
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I420\|I501
COD_ICD_9	4281
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Nonischemic cardiomyopathy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4374	1567	2807
Unadjusted period prevalence (%)	1.03	0.56	1.29
Median age at first event (years)	66.04	67.48	65.24

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4478: Matched controls
44737

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1LA

NOMESCO Finland

16.6

316.8

270

172

B01AF02

ATC

apixaban; oral

3.9

315.2

1185

3797

I48.1

ICD-10 Finland

Persistent atrial fibrillation

6.5

312.6

552

948

I42.8

ICD-10 Finland

Other cardiomyopathies

93.3

310.0

162

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.8

309.8

1206

3952

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

19.2

307.7

265

146

C07AB07

ATC

bisoprolol; oral

10.4

307.7

3710

14145

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

8.3

307.7

2402

5461

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.5

307.7

2912

15592

I50.0

ICD-10 Finland

Congestive heart failure

16.1

307.7

1290

1095

TFP20

NOMESCO Finland

Cardiodefibrillation

6.5

307.7

880

1618

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

8.1

307.7

1920

3803

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

151.6

307.7

189

I48

ICD-10 Finland

Atrial fibrillation and flutter

5.9

307.7

2183

6198

I47.2

ICD-10 Finland

Ventricular tachycardia

19.5

307.7

307

168

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

12.2

307.7

658

622

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2073.5

307.7

524

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

1718.4

307.7

454

C03CA01

ATC

furosemide; systemic

12.6

307.7

3360

8624

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

13.7

307.7

871

777

XF404

NOMESCO Finland

Ambulatory ECG

5.5

307.7

795

1675

250, ,

Kela drug reimbursment

57.2

307.7

767

161

K77

ICPC

Heart failure

14.6

307.7

384

286

201

Kela drug reimbursment

Chronic cardiac insufficiency

76.6

307.7

2069

496

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

12.6

307.7

1105

1133

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.4

307.7

597

1058

C01AA05

ATC

digoxin; systemic

10.2

307.7

1222

1589

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.1

307.7

1679

4686

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

130.2

307.7

676

A10BK01

ATC

dapagliflozin; oral

6.8

307.7

962

1731

207

Kela drug reimbursment

Chronic arrhythmias

6.9

307.7

1830

4063

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

19.3

307.7

2008

1805

I50.1

ICD-10 Finland

Left ventricular failure

4480.7

307.7

3123

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

23.0

307.7

415

198

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4954.1

307.7

2254

C09DX04

ATC

valsartan and sacubitril; oral

1877.5

307.7

486

I50

ICD-10 Finland

Heart failure

11.5

307.7

448

429

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

38.9

307.7

369

103

C01BD01

ATC

amiodarone; systemic

19.6

307.7

541

311

C03DA01

ATC

spironolactone; oral

18.7

307.7

2340

2472

AN1

Coronary angiography

16.8

307.7

709

496

C09AA05

ATC

ramipril; oral

7.2

307.7

2431

6351

I48.2

ICD-10 Finland

Chronic atrial fibrillation

8.1

307.7

689

987

I50.9

ICD-10 Finland

Heart failure, unspecified

21.4

307.7

2623

2774

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

5.0

307.7

1516

4189

B01AA03

ATC

warfarin; systemic

5.6

307.7

1841

4997

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

4.9

307.1

771

1822

A10BK03

ATC

empagliflozin; oral

4.2

277.2

869

2430

R06.0

ICD-10 Finland

Dyspnoea

3.1

267.9

1631

6966

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

4.4

266.0

778

2062

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

72.7

260.8

141

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

6.7

252.5

423

685

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

44.0

237.0

141

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

109.1

227.7

117

K78

ICPC

Atrial fibrillation/flutter

4.2

227.3

697

1902

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

13.6

222.7

211

162

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

10.6

203.0

227

225

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

8.7

197.9

256

308

Angiography of the heart and coronary arteries

12.9

191.3

187

151

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

11.4

190.4

201

183

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

6.0

182.8

337

597

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.6

180.5

684

2144

XF400

NOMESCO Finland

ECG with 12 standard connections

3.0

178.1

974

3805

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

1847.6

176.1

170

K84

ICPC

Heart disease other

8.1

174.3

240

311

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

256.7

169.7

173

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

28.0

165.4

112

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

28.6

162.2

109

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

8.1

159.0

218

281

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

4.4

156.7

422

1034

I44.2

ICD-10 Finland

Atrioventricular block, complete

6.4

153.8

264

435

M04AA01

ATC

allopurinol; systemic

2.8

150.8

900

3657

TFP34

NOMESCO Finland

Electrophysiological investigation

5.6

138.6

271

506

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

10.8

137.5

150

143

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

22.5

134.8

AP1

Catheterization of the left side of the heart

19.7

131.3

102

WX892

NOMESCO Finland

Monitored bed care

3.5

130.8

494

1531

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

8.8

129.5

165

194

WX872

NOMESCO Finland

Intensive care

4.5

120.8

305

708

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

12.0

119.5

121

103

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.4

117.6

465

1480

R02

ICPC

Shortness of breath/dyspnoea

2.7

117.1

753

3147

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

41.8

116.1

XF640, ,

NOMESCO Finland

5.5

108.0

215

407

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

106.8

646

2610

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.9

99.6

157

236

I34.1

ICD-10 Finland

Mitral (valve) prolapse

4.9

99.6

225

476

1CX08, ,

NOMESCO Finland

121.7

99.4

107

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.0

98.5

295

777

XF402

NOMESCO Finland

ECG with work load test

3.0

97.7

484

1754

C07AA07

ATC

sotalol; systemic

4.3

96.8

261

636

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

5.7

95.4

180

324

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

94.7

1448

8601

I49.3

ICD-10 Finland

Ventricular premature depolarization

3.1

92.8

432

1510

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

53.6

92.7

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

7.9

91.7

127

165

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

6.2

91.0

157

259

XF409

NOMESCO Finland

Other special ECG

16.3

90.7

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

885.0

89.0

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.6

88.0

303

878

ZXD05

NOMESCO Finland

Urgent procedure

2.0

88.0

1280

7436

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.9

86.5

438

1603

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

86.4

1099

6078

M10.9

ICD-10 Finland

Gout, unspecified

2.8

86.0

476

1827

ZX120

NOMESCO Finland

Intravenous

2.6

80.8

513

2108

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

80.5

611

2731

TFJ02

NOMESCO Finland

Muscle biopsy of heart

108.2

78.1

H02AB06

ATC

prednisolone; systemic

1.8

77.9

2176

15423

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

77.9

1008

5583

FL1AC

NOMESCO Finland

Left cardioangiography

12.6

77.7

I42

ICD-10 Finland

Cardiomyopathy

257.7

74.6

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

15.8

74.3

C07AB02

ATC

metoprolol; systemic

2.1

74.2

834

4376

A12BA01

ATC

potassium chloride; oral

3.6

72.3

244

697

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

362.7

71.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

69.4

688

3430

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.7

69.0

400

1567

C07AG02

ATC

carvedilol; oral

2.9

66.5

334

1212

A46

ICD-10 Finland

Erysipelas

2.0

66.4

812

4378

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.7

65.3

214

599

Z94.1

ICD-10 Finland

Heart transplant status

82.5

65.1

AP4

Myocardial biopsy

140.0

65.0

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

10.1

64.6

127

Kela drug reimbursment

Transplant complication

5.9

64.3

116

200

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.7

62.9

209

590

ZXE00

NOMESCO Finland

One hour or less

1.7

62.9

1633

11135

I49.5

ICD-10 Finland

Sick sinus syndrome

3.4

62.7

231

698

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.2

62.0

255

825

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.9

61.9

312

1134

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

61.8

647

3285

TK800

NOMESCO Finland

Hemodialysis

4.7

61.6

144

313

TFP35

NOMESCO Finland

Electroanatomical mapping

5.6

61.5

117

212

B01AB05

ATC

enoxaparin; parenteral

1.7

61.2

1456

9669

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

8.3

60.6

K99

ICPC

Cardiovascular disease other

3.8

59.3

185

500

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.7

59.3

336

1298

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

82.4

58.0

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

58.0

1144

7177

L04AA06

ATC

mycophenolic acid; systemic

4.9

57.3

127

264

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

56.7

549

2698

C01DA14

ATC

isosorbide mononitrate; oral

2.9

56.7

276

983

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

554.4

55.7

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

19.7

55.4

B01AF01

ATC

rivaroxaban; oral

2.0

55.4

689

3717

K83

ICPC

Heart valve disease NOS

6.5

54.0

137

R4110

NOMESCO Finland

Physiotherapy

1.7

52.9

1238

8122

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

52.2

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

50.9

375

1640

AA1AD

NOMESCO Finland

CT of head and brain

1.7

50.8

1374

9349

E87.5

ICD-10 Finland

Hyperkalaemia

4.4

50.4

127

293

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

50.4

511

2552

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

50.3

603

3204

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

50.1

737

4200

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

5.0

49.9

108

220

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.7

49.6

117

256

L04AD02

ATC

tacrolimus; systemic

6.3

47.4

129

C09AA02

ATC

enalapril; systemic

1.8

47.2

903

5568

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

46.9

1190

7933

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

11.0

46.8

R03BB04

ATC

tiotropium bromide; inhalant

2.1

46.1

499

2550

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

6.4

46.0

120

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

10.1

46.0

E05.89

ICD-10 Finland

Other thyrotoxicosis

14.1

45.9

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

5.8

45.8

147

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

45.7

1193

8002

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.9

44.2

130

337

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

11.3

43.9

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.1

43.9

192

643

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.1

43.9

187

617

Z3231

NOMESCO Finland

Registered nurse

1.7

43.7

1167

7860

AP2

Catheterization of the right side of the heart

16.2

43.5

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

10.1

43.3

B01AF03

ATC

edoxaban; oral

3.5

42.6

148

430

Z2221

NOMESCO Finland

Medical doctor

1.7

42.5

1086

7225

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

216.8

41.9

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

79.2

41.9

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.8

41.8

130

351

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.0

41.2

188

645

Initial pacemaker installation

9.9

40.9

C09CA03

ATC

valsartan; oral

2.0

40.8

458

2368

M10.0

ICD-10 Finland

Idiopathic gout

2.8

40.8

208

759

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

40.7

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.2

40.4

369

1763

WX722

NOMESCO Finland

PEEP

2.6

40.3

234

913

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

10.1

39.8

I48.3

ICD-10 Finland

Typical atrial flutter

4.8

39.6

191

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

9.3

39.1

A10BA02

ATC

metformin; oral

1.6

38.5

1221

8529

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

38.4

203

755

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

9.3

38.3

FN1AD

NOMESCO Finland

CT of coronary arteries

4.8

38.3

181

I47.1

ICD-10 Finland

Supraventricular tachycardia

2.7

38.0

204

765

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

6.9

37.7

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

37.5

134

397

E66.8

ICD-10 Finland

Other obesity

2.7

37.4

211

811

C09AA04

ATC

perindopril; oral

2.5

37.4

251

1050

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

55.5

37.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

37.2

412

2117

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.6

36.7

226

908

N19

ICD-10 Finland

Unspecified kidney failure

2.7

36.6

200

757

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

359.9

36.0

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

4.1

35.9

245

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

35.8

249

1058

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

8.1

35.8

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

12.6

35.7

C08DA01

ATC

verapamil; systemic

2.7

35.2

199

766

H03BB01

ATC

carbimazole; oral

2.8

35.2

175

630

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

4.5

34.5

189

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

34.4

529

3034

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

34.1

763

4868

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

34.1

280

1280

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

34.1

1037

7143

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

3.2

34.0

139

448

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

5.4

33.9

126

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.2

33.8

139

449

AS4

Physiological pacemaker insertion DDD (R)

4.7

33.8

172

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

5.6

33.7

116

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.3

33.6

254

1121

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

33.4

351

1767

Catheterization and pressure measurement of the left side of the heart

9.6

33.2

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

32.8

244

1069

S97

ICPC

Chronic ulcer skin

2.1

32.7

317

1548

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.8

32.5

168

618

I44.1

ICD-10 Finland

Atrioventricular block, second degree

3.5

32.3

113

330

M10

ICD-10 Finland

Gout

2.3

32.3

243

1070

J96.1

ICD-10 Finland

Chronic respiratory failure

3.3

32.2

123

380

I48.4

ICD-10 Finland

Atypical atrial flutter

6.8

32.2

R03AC02

ATC

salbutamol; inhalant

1.5

31.9

2058

16511

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

6.1

31.8

TK810

NOMESCO Finland

Hemofiltration

6.7

31.8

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

31.8

734

4716

A10BH05

ATC

linagliptin; oral

2.3

31.7

240

1059

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

31.7

318

1573

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

31.6

193

772

B01AE07

ATC

dabigatran etexilate; oral

2.5

31.6

202

826

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.1

31.5

131

T90

ICPC

Diabetes non-insulin dependent

1.6

31.2

1048

7362

WX740

NOMESCO Finland

Nitrogen oxide therapy

39.3

31.2

C01BC04

ATC

flecainide; systemic

2.6

31.1

185

731

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

30.9

169

640

A11CC03

ATC

alfacalcidol; systemic

3.2

30.7

120

376

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.4

30.6

224

974

SPAT1263

SPAT

Sampling

1.5

30.5

1595

12261

J81

ICD-10 Finland

Pulmonary oedema

10.7

30.4

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

31.0

30.3

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

30.2

I51.4

ICD-10 Finland

Myocarditis, unspecified

8.7

30.1

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

30.1

1481

11247

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

304.2

29.8

M01AE01

ATC

ibuprofen; systemic, rectal

0.7

29.6

3071

34134

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

29.6

1378

10342

3A064, ,

NOMESCO Finland

9.8

29.4

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

11.1

29.3

JN4AD

NOMESCO Finland

Body CT examination

1.7

29.2

571

3503

R55

ICD-10 Finland

Syncope and collapse

1.8

29.0

479

2799

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

9.5

28.8

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

293.6

28.8

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

293.6

28.8

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

28.8

419

2356

AS7

Arrhythmia pacemaker insertion VVI (R) S

104.0

28.7

3AC01, ,

NOMESCO Finland

5.4

28.5

105

J01MA12

ATC

levofloxacin; systemic

1.6

28.0

810

5483

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

27.4

236

1099

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.2

27.4

108

341

R04.0

ICD-10 Finland

Epistaxis

1.9

27.3

346

1860

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

27.2

250

1195

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

53.6

27.2

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

27.1

195

Electrophysiological Special Examination

7.0

27.1

XG466

NOMESCO Finland

Sleep oxymetry

2.6

26.6

152

589

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.0

26.3

117

396

AS2

Ventricular pacemaker insertion VVI (R)

6.6

26.3

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

26.3

107

344

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

26.2

1412

10843

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

4.3

26.2

157

T92

ICPC

Gout

2.9

26.0

123

431

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

25.9

1671

13244

M01AH05

ATC

etoricoxib; oral

0.7

25.9

1742

21142

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

25.7

179

761

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

25.7

755

5118

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.1

25.7

172

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.2

25.7

229

1082

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

25.3

247

1209

205

Kela drug reimbursment

Chronic hypertension

1.5

25.2

1147

8521

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

25.1

217

1013

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

6.0

25.1

A02BC02

ATC

pantoprazole; systemic

1.4

24.9

2754

23850

A10AE04

ATC

insulin glargine; parenteral

1.8

24.9

379

2158

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

24.8

484

2960

J01DB01

ATC

cefalexin; oral

1.5

24.7

3382

30388

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.1

24.7

164

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.1

24.7

247

1219

J96.0

ICD-10 Finland

Acute respiratory failure

3.9

24.7

186

J01FF01

ATC

clindamycin; systemic

1.5

24.7

1042

7622

J01MA14

ATC

moxifloxacin; systemic

1.8

24.5

374

2132

AP3

Catheterization of the right and left side of the heart

27.7

24.4

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

24.4

192

862

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

48.6

24.3

AC4

MVP

6.7

24.2

3025

Kela drug reimbursment

Calcium carbonate

6.2

24.0

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

23.9

231

1126

C07AB03

ATC

atenolol; systemic

2.1

23.7

236

1163

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.7

23.4

198

N17.8

ICD-10 Finland

Other acute renal failure

3.7

23.2

204

A12AA04

ATC

calcium carbonate; oral

3.7

23.1

200

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

23.0

517

3279

Catheter ablation of arrhythmia

6.4

23.0

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

8.0

23.0

FXE00

NOMESCO Finland

Use of ECLA

+∞

22.9

I95.9

ICD-10 Finland

Hypotension, unspecified

3.6

22.8

216

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

22.6

297

1613

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

40.2

22.6

212

Kela drug reimbursment

Gout

2.8

22.6

110

392

N02BE01

ATC

paracetamol; systemic, rectal

1.5

22.6

3731

34351

I45.9

ICD-10 Finland

Conduction disorder, unspecified

5.0

22.5

AQ1

Conventional electrophysiological examination

4.3

22.5

137

Q21.10

ICD-10 Finland

Persistent ostium secundum

8.8

22.4

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

22.3

284

1527

WX882

NOMESCO Finland

High dependency care

2.6

22.2

126

487

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.1

22.1

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

22.0

738

5137

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

21.9

853

6120

C10AA05

ATC

atorvastatin; oral

1.4

21.9

1594

12800

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

21.7

539

3502

E86

ICD-10 Finland

Volume depletion

2.6

21.1

121

470

A10BJ06

ATC

semaglutide; parenteral

2.1

21.1

211

1042

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

21.0

542

3556

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

21.0

344

2002

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.8

20.9

300

1676

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

16.6

20.9

132

Kela drug reimbursment

Sarcoidosis

4.9

20.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

20.7

472

3003

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

77.1

20.7

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

20.7

432

2688

G47.3

ICD-10 Finland

Sleep apnoea

1.4

20.6

927

6833

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

20.4

104

380

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.6

20.4

115

443

R50.9

ICD-10 Finland

Fever, unspecified

1.6

20.4

599

4047

Q23.11

ICD-10 Finland

Bicuspid aortic valve

4.2

20.2

131

PD5AD

NOMESCO Finland

CT of aorta

2.8

20.1

350

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

20.1

140

597

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

5.6

19.9

Z3226

NOMESCO Finland

Physiotherapist

1.5

19.8

665

4623

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

19.7

1393

11083

AB1

AVR mechanical

8.2

19.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.2

19.5

249

A08

ICPC

Swelling

1.9

19.5

255

1384

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

19.4

1534

12414

C03AA03

ATC

hydrochlorothiazide; oral

1.7

19.4

351

2100

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.0

19.4

276

A10AC01

ATC

insulin (human); parenteral

1.9

19.3

257

1403

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.7

19.2

163

FM1CD

NOMESCO Finland

Very extensive CT of heart

8.4

19.2

H02AB07

ATC

prednisone; oral

1.6

19.2

517

3421

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.1

19.1

124

FM1EE, ,

SPAT

3.3

18.9

218

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

18.9

1114

8595

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

18.9

1037

7907

L04AX01

ATC

azathioprine; systemic

2.2

18.8

160

742

K29

ICPC

Cardiovascular sympt/complt other

2.1

18.8

184

902

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

18.7

194

972

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

18.7

2611

22924

R4190

NOMESCO Finland

Nutritional therapy

2.2

18.6

165

778

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

190.6

18.5

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

14.2

18.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

18.5

1306

10368

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

18.5

124

520

K28

ICPC

Limited function/disability (K)

2.6

18.5

104

401

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

5.2

18.4

SPAT1097

SPAT

Recording of ECG

1.5

18.3

535

3605

A41.8

ICD-10 Finland

Other specified sepsis

2.8

18.3

346

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

44.1

18.2

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

6.0

18.2

N18.0

ICD-10 Finland

End-stage renal disease

3.9

18.2

133

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

18.2

165

786

Z2446

NOMESCO Finland

Social worker

1.9

18.1

235

1273

Catheterization and pressure measurement of the right side of the heart

14.4

18.0

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

18.0

424

2715

K80

ICPC

Cardiac arrhythmia NOS

1.7

18.0

333

2003

7AX01, ,

NOMESCO Finland

52.7

17.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

17.9

316

XF622

NOMESCO Finland

Measurement of minute volume of heart

7.3

17.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

17.8

996

7609

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.7

17.5

FM1AD

NOMESCO Finland

CT of heart

7.8

17.4

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.2

17.4

147

681

I45.3

ICD-10 Finland

Trifascicular block

5.1

17.4

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

6.0

17.3

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

5.3

17.3

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

17.2

216

1157

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

17.2

231

1265

N02AX02

ATC

tramadol; systemic, rectal

1.3

17.1

1678

13955

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.4

17.0

ZX108

NOMESCO Finland

Inhalation

4.4

17.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

17.0

230

1262

I51.3

ICD-10 Finland

Intracardiac thrombosis, not elsewhere classified

25.6

16.9

J94.8

ICD-10 Finland

Other specified pleural conditions

2.9

16.8

272

160

Kela drug reimbursment

exenatide

2.9

16.8

283

A10BH01

ATC

sitagliptin; oral

1.6

16.7

371

2340

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

3.8

16.7

132

Z71.8

ICD-10 Finland

Other specified counselling

1.4

16.7

1207

9588

WX930

NOMESCO Finland

Thepapeutic hypothermia

35.1

16.6

R04.2

ICD-10 Finland

Haemoptysis

2.1

16.6

153

733

342

Kela drug reimbursment

Dronedarone

4.3

16.6

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.5

16.6

106

435

FPJ21

NOMESCO Finland

Revision of cardioverter-defibrillator with ventricular electrode

90.3

16.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

16.5

214

1157

A10AB05

ATC

insulin aspart; parenteral

1.8

16.5

265

1532

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

5.7

16.3

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

14.3

16.3

WX730

NOMESCO Finland

Conventional respirator

3.0

16.2

229

I44.0

ICD-10 Finland

Atrioventricular block, first degree

2.9

16.2

261

WZC30

NOMESCO Finland

Teaching

1.5

16.2

651

4679

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.4

16.1

164

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

16.1

174

885

B01AB04

ATC

dalteparin; parenteral

1.9

16.1

205

1103

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

16.1

525

3618

WX902

NOMESCO Finland

External defibrillation of heart

6.0

16.0

FA1AC

NOMESCO Finland

Upper cavography

47.6

16.0

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

5.6

16.0

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

2.9

16.0

247

SPAT1260

SPAT

Consultation of another employee

1.5

15.8

632

4535

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

15.8

601

4272

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

15.8

241

1373

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

15.7

114

495

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

15.7

181

942

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

15.6

122

547

Cardiac muscle biopsy

+∞

15.6

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

15.6

626

4493

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

15.6

141

671

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.3

15.6

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

15.6

177

917

WX890

NOMESCO Finland

Intesive care monitoring

5.6

15.5

XW000

NOMESCO Finland

Bone marrow biopsy

2.0

15.5

177

918

WW500

NOMESCO Finland

Blood transfusion

2.0

15.5

165

835

FXM00

NOMESCO Finland

Removal of extra-, para- or intracorporeal VAD

160.4

15.5

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.4

15.5

109

468

SPAT1255

SPAT

Intravenous administration of medicine

1.7

15.4

267

1578

C01BA01

ATC

quinidine; oral

4.7

15.4

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.3

257

1504

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.3

15.3

110

477

SPAT1254

SPAT

Administration of medicine

1.5

15.2

545

3828

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

15.1

593

4237

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.5

15.1

375

R2110

NOMESCO Finland

Giving the first information

1.9

15.1

190

1018

742, ,

NOMESCO Finland

11.8

15.0

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

14.9

497

6985

L28

ICPC

Limited function/disability (L)

1.4

14.9

778

5852

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

3.8

14.9

120

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

14.7

453

3081

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

14.7

149

741

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

25.1

14.7

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

25.1

14.7

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

21.1

14.6

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

80.3

14.6

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

14.6

282

1718

C09CA01

ATC

losartan; oral

1.3

14.6

1019

8029

SPAT1252

SPAT

Overall medication plan or its review

1.7

14.5

258

1535

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

2.9

14.4

223

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

5.8

14.4

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

14.3

936

7297

J01CA04

ATC

amoxicillin; systemic

1.3

14.3

3151

28860

I13.2

ICD-10 Finland

Hypertensive heart and renal disease with both (congestive) heart failure and renal failure

5.0

14.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

14.2

515

3621

I51.7

ICD-10 Finland

Cardiomegaly

5.3

14.2

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

42.6

14.1

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

6.4

14.1

C09AA01

ATC

captopril; oral

2.9

14.1

232

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

3.9

13.9

103

C08DB01

ATC

diltiazem; oral

1.9

13.9

169

896

S18

ICPC

Laceration/cut

1.3

13.7

1905

16434

SPAT1262

SPAT

Handing over of treatment supplies

1.4

13.6

650

4808

A10BJ02

ATC

liraglutide; parenteral

2.3

13.6

101

444

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

13.6

845

6530

ASA

Insertion of a biventricular pacemaker VVI (R) S

75.3

13.6

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

+∞

13.5

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.5

1608

13601

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.0

13.5

189

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

13.5

206

1175

I44.6

ICD-10 Finland

Other and unspecified fascicular block

16.2

13.4

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.5

13.4

134

R60.0

ICD-10 Finland

Localized oedema

1.5

13.4

498

3519

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

13.4

222

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

4.3

13.3

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.8

13.3

215

1247

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.9

13.2

202

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

13.2

1879

16233

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.1

13.1

176

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.3

13.1

146

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

13.1

214

TGC00

NOMESCO Finland

Bronchial lavation

2.2

13.0

107

491

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

5.9

13.0

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

11.0

13.0

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

13.0

107

492

J20

ICD-10 Finland

Acute bronchitis

1.6

12.9

351

2323

AB2

AVR bio, stent

6.1

12.9

XX9XB

NOMESCO Finland

Other X-ray examination with contrast

5.6

12.9

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

12.9

227

1349

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

12.8

233

1395

5253

FHL

Cardiac lung machine

14.0

12.7

WX402

NOMESCO Finland

General anaesthesia

1.4

12.7

803

6214

A10BB12

ATC

glimepiride; oral

1.7

12.6

238

1442

Z94.0

ICD-10 Finland

Kidney transplant status

3.4

12.5

135

C02EA02, ,

ATC

1.9

12.5

161

870

FPJ11

NOMESCO Finland

Revision of biventricular CRT-P (VVIR) generator

+∞

12.5

XFP02, ,

NOMESCO Finland

17.3

12.5

SPAT1310

SPAT

Counselling related to known health issue

1.3

12.4

1090

8838

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

12.4

500

3584

C01EB17

ATC

ivabradine; oral

130.2

12.4

K08.3

ICD-10 Finland

Retained dental root

1.6

12.4

314

2044

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

12.4

225

1348

N05CF01

ATC

zopiclone; oral

1.3

12.3

1201

9874

C01BD07

ATC

dronedarone; oral

4.0

12.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

12.2

136

700

SPAT1229

SPAT

Assessment of need for aid

1.6

12.2

289

1851

L04AD01

ATC

ciclosporin; systemic

2.6

12.2

268

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

12.2

415

2882

R18

ICD-10 Finland

Ascites

2.3

12.1

384

A28

ICPC

Limited function/disability NOS

1.4

12.1

756

5840

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

12.0

157

853

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

18.0

12.0

K07

ICPC

Swollen ankles/oedema

1.8

12.0

190

1095

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.7

11.9

101

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

11.8

143

758

SPAT1325

SPAT

Vaccination

1.3

11.8

1223

10125

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

11.8

160

881

C01BB02

ATC

mexiletine; systemic

14.7

11.8

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.6

11.7

244

V03AE01

ATC

polystyrene sulfonate; oral

2.7

11.7

227

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

11.6

601

4500

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

30.1

11.6

I95.2

ICD-10 Finland

Hypotension due to drugs

4.0

11.6

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

5.5

11.6

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.6

11.6

103

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

11.6

459

3281

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

11.5

386

2673

283

Kela drug reimbursment

Ivabradine

+∞

11.5

OAB43, ,

SPAT

0.7

11.4

433

5971

I45.2

ICD-10 Finland

Bifascicular block

4.0

11.4

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.5

11.4

L04AA01

ATC

[U] ciclosporin

2.9

11.3

181

5AB14, ,

NOMESCO Finland

11.8

11.3

C10AA01

ATC

simvastatin; oral

1.3

11.2

1516

12942

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.0

11.2

161

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

11.2

317

2118

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

20.0

11.1

R06

ICPC

Nose bleed/epistaxis

2.1

11.0

466

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

5.7

11.0

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

10.9

329

2227

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

10.8

1658

Initial installation of the atrial pacemaker

11.9

10.8

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

9.6

10.7

ZX197, ,

NOMESCO Finland

17.8

10.7

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

10.7

517

3827

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.2

10.7

134

SPAT1104

SPAT

Monitoring of emergency patient

1.6

10.6

220

1365

J01FA06

ATC

roxithromycin; oral

1.3

10.6

1362

11541

WX002

NOMESCO Finland

Sedation and analgesia

1.3

10.6

711

5538

JN4BD

NOMESCO Finland

Extensive body CT

1.4

10.6

417

2977

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

3.7

10.5

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.9

10.5

AK1

HTX (heart transplant)

+∞

10.4

FQA00

NOMESCO Finland

Orthotopic transplantation of heart

+∞

10.4

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

5.4

10.4

G04BE03

ATC

sildenafil; oral

2.2

10.3

367

J01DA01

ATC

[U] cefalexin

1.2

10.3

2262

20302

SPAT1285

SPAT

Provision of consultation response

1.7

10.3

175

1032

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

10.2

340

2348

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.4

10.2

286

I11

ICD-10 Finland

Hypertensive heart disease

3.8

10.2

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

10.1

428

H02AB04

ATC

methylprednisolone; systemic

1.4

10.1

479

3533

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.2

10.0

364

TFP50

NOMESCO Finland

Ablation treatment of idiopathic right ventricle tachycardia

11.3

10.0

K92.1

ICD-10 Finland

Melaena

1.6

10.0

206

1277

R03BA02

ATC

budesonide; inhalant

1.4

9.9

566

4301

E06.4

ICD-10 Finland

Drug-induced thyroiditis

16.7

9.9

AH3

Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery

16.7

9.9

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

9.8

669

5220

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

4.3

9.8

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.2

9.8

368

ZYC03

NOMESCO Finland

Remote contact, text-based

3.6

9.8

C01BA03

ATC

disopyramide; systemic

4.0

9.7

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

9.5

9.7

NHQ40

NOMESCO Finland

Amputation of toe

2.5

9.7

244

WX213

NOMESCO Finland

Lower leg blockade

3.3

9.7

111

R03BB01

ATC

ipratropium bromide; inhalant

1.8

9.7

147

839

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.8

9.7

164

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

13.4

9.6

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

9.6

2691

24671

RS221, ,

NOMESCO Finland

2.7

9.6

187

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

15.0

9.5

I34

ICD-10 Finland

Nonrheumatic mitral valve disorders

9.1

9.5

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.0

9.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

9.5

108

563

A10BX07

ATC

[U] liraglutide

2.9

9.4

155

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.1

9.4

407

137

Kela drug reimbursment

Uraemia requiring dialysis

3.3

9.4

103

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

9.4

248

SPAT1211

SPAT

Application of soft bandage

1.5

9.4

302

2072

XF406

NOMESCO Finland

High resolution ECG

30.0

9.4

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.7

9.4

178

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

9.3

376

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.4

9.3

262

Z50.0

ICD-10 Finland

Cardiac rehabilitation

8.7

9.3

C08CA02

ATC

felodipine; oral

1.4

9.2

347

2457

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

13.7

9.2

V03AE02

ATC

sevelamer; oral

4.2

9.1

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.3

9.1

100

WW200

NOMESCO Finland

Immunization

2.0

9.1

466

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.4

9.1

270

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

3.9

9.1

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

7.7

9.1

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.4

9.1

240

Z49.2

ICD-10 Finland

Other dialysis

3.6

9.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

9.0

132

745

162

Kela drug reimbursment

liraglutide

2.9

9.0

137

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

8.3

9.0

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

9.0

124

687

AS5

Biventricular heart failure pacemaker insertion VVI (R)

36.7

9.0

FN1BE

NOMESCO Finland

Ultrasound examination of coronary arteries through catheter

36.7

9.0

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.3

9.0

101

R06.2

ICD-10 Finland

Wheezing

1.7

9.0

143

828

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

9.0

196

1234

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

9.0

353

2519

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

9.0

251

1674

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.2

8.9

102

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

8.9

514

3914

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

12.5

8.8

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

7.9

8.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.8

1516

13201

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

8.8

244

SPAT1301

SPAT

No procedures

1.2

8.8

1086

9131

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

8.7

103

544

OAA67, ,

SPAT

0.7

8.7

228

3379

AC2

MVR bio

14.0

8.7

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

8.7

434

M01AB05

ATC

diclofenac; systemic, rectal

0.8

8.6

2080

22881

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.6

106

567

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

6.6

8.6

E66.0

ICD-10 Finland

Obesity due to excess calories

3.1

8.6

109

R05

ICPC

Cough

1.3

8.6

824

6721

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.9

8.6

104

554

J01CF05

ATC

flucloxacillin; systemic

1.5

8.6

244

1633

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

3.6

8.5

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

8.5

350

2519

ZXA05

NOMESCO Finland

Left side

1.3

8.5

893

7366

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

20.0

8.5

A03

ICPC

Fever

1.3

8.4

495

3775

A10AE05

ATC

insulin detemir; parenteral

1.7

8.4

156

942

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.2

8.4

FM2CE, ,

NOMESCO Finland

7.3

8.4

FWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of heart and major thoracic vessels

90.1

8.4

D86.0

ICD-10 Finland

Sarcoidosis of lung

2.6

8.4

177

EBA00

NOMESCO Finland

Extraction of tooth

1.2

8.4

1281

11008

AD1

TVP

12.8

8.4

3058, ,

Kela drug reimbursment

+∞

8.3

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.4

8.3

R03DA04

ATC

theophylline; systemic, rectal

1.6

8.3

194

1244

B05DB

ATC

Hypertonic solutions

3.6

8.3

WVA20

NOMESCO Finland

Medicine administration

1.9

8.2

519

K22

ICPC

Risk factor cardiovascular disease

1.6

8.2

206

1340

XF620

NOMESCO Finland

Examination of circulation with color method

4.1

8.2

NFQ20

NOMESCO Finland

Amputation of femur

3.1

8.2

107

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.1

8.2

335

I95.8

ICD-10 Finland

Other hypotension

3.8

8.2

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.1

8.2

375

XG405

NOMESCO Finland

Education on PEF monitoring

2.4

8.2

227

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.3

8.2

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

4.5

8.1

N06DA02

ATC

donepezil; oral

0.6

8.1

114

1956

Mitral valve Replacement (MVR)

17.2

8.1

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

8.1

126

727

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.9

8.0

524

T82

ICPC

Obesity

1.8

8.0

114

640

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

8.0

516

3991

FM1DE, ,

SPAT

3.6

8.0

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

8.0

393

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

8.0

1324

11465

GX1K5

NOMESCO Finland

Diffusion capacity

3.1

7.9

104

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.0

7.9

414

M10.2

ICD-10 Finland

Drug-induced gout

7.2

7.9

I97.0

ICD-10 Finland

Postcardiotomy syndrome

7.2

7.9

K60

ICPC

Cardiovascular, Result test/procedure

2.9

7.9

120

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

7.9

158

974

SPAT1251

SPAT

Organisation of medication

1.8

7.8

110

615

Z92.1

ICD-10 Finland

Personal history of long-term (current) use of anticoagulants

8.4

7.8

OAB72

NOMESCO Finland

Weight control and weight loss guidance

3.5

7.8

FN1BD

NOMESCO Finland

Extensive CT of coronary arteries

10.8

7.8

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.3

7.7

227

RS222, ,

NOMESCO Finland

2.6

7.7

167

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.6

7.7

120, ,

NOMESCO Finland

45.0

7.7

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

15.0

7.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.7

2453

22534

R03AC13

ATC

formoterol; inhalant

1.6

7.6

158

983

K05

ICPC

Irregular heartbeat other

1.8

7.6

114

650

R03AC03

ATC

terbutaline; inhalant

1.4

7.6

412

3104

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

7.6

226

1528

OAA80, ,

SPAT

0.6

7.6

131

2132

3A149, ,

NOMESCO Finland

25.0

7.6

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.8

7.6

129

J45.8

ICD-10 Finland

Mixed asthma

1.9

7.6

499

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.6

7.6

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.2

7.5

268

V03AE03

ATC

lanthanum carbonate; oral

6.1

7.5

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

4.1

7.5

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.2

7.5

288

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

7.5

105

587

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

7.5

156

974

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

7.4

233

1592

I44

ICD-10 Finland

Atrioventricular and left bundle-branch block

80.2

7.4

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

4.4

7.4

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.1

7.4

303

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

7.4

277

1961

R11

ICD-10 Finland

Nausea and vomiting

1.4

7.4

264

1853

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

3.3

7.4

2BD01, ,

NOMESCO Finland

8.3

7.3

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.6

7.3

138

2196

257, ,

Kela drug reimbursment

+∞

7.3

FPE26

NOMESCO Finland

Implantation of permanent biventricular pacemaker, transvenous route

+∞

7.3

NGQ20

NOMESCO Finland

Amputation of lower leg

3.5

7.2

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.8

7.2

110

631

P15

ICPC

Chronic alcohol abuse

1.8

7.2

104

587

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

7.2

147

913

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

7.2

158

999

K81.0

ICD-10 Finland

Acute cholecystitis

2.0

7.2

381

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

7.2

132

798

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

30.0

7.1

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

30.0

7.1

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

7.1

138

845

WX720

NOMESCO Finland

Own respiration

1.6

7.1

139

853

L03AA13

ATC

pegfilgrastim; parenteral

1.6

7.1

144

893

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

7.9

7.1

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

6.0

7.1

WX900

NOMESCO Finland

Resuscitation

5.6

7.0

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

7.0

543

4303

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

7.0

282

2023

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.8

7.0

535

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

4.4

6.9

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

4.4

6.9

L03AA02

ATC

filgrastim; parenteral

1.7

6.9

111

647

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

5.8

6.9

A04

ICPC

Weakness/tiredness general

1.3

6.8

507

3996

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

6.8

451

5734

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

6.8

333

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

2.9

6.8

103

45499

ICD-8 Finland

Varicose veins of lower extremities, Other and unspecified, without ulcer

1.5

6.8

201

1358

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

2.7

6.8

131

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

6.7

6.8

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

6.8

431

3325

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

6.8

309

2265

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

6.8

128

780

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.7

337

2507

Q21.19

ICD-10 Finland

Atrial septal defect NOS

5.6

6.7

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.0

6.7

328

TFP59

NOMESCO Finland

Ablation treatment of other ventricular tachycardia

16.7

6.7

FM1BG

NOMESCO Finland

MRI examination of heart with high intensity magnet

16.7

6.7

FXG00

NOMESCO Finland

Insertion and use of IABP

16.7

6.7

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.5

6.7

161

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

0.5

6.7

1029

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

6.7

171

1120

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.1

6.7

R28

ICPC

Limited function/disability (R)

2.3

6.7

217

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.1

6.7

282

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

6.7

298

2177

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.2

6.7

243

J01XX08

ATC

linezolid; systemic

3.0

6.6

E87.6

ICD-10 Finland

Hypokalaemia

1.7

6.6

118

708

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

6.6

333

2481

XPX00

NOMESCO Finland

Intraoperative angiography

4.0

6.6

SPAT1312

SPAT

General health counselling

1.2

6.6

1008

8630

S76

ICPC

Skin infection other

1.5

6.6

191

1286

NA3BG, ,

SPAT

0.4

6.6

773

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.4

6.6

175

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

6.6

129

794

ZXE90

NOMESCO Finland

More than 22 hours

3.4

6.5

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

4.2

6.5

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

10.0

6.5

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

6.5

141

889

R03BA05

ATC

fluticasone; inhalant

1.3

6.5

543

4348

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

6.5

168

1105

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.1

6.4

253

B05DA

ATC

Isotonic solutions

3.1

6.4

R5110, ,

SPAT

1.4

6.4

319

2372

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

7.4

6.4

E87.2

ICD-10 Finland

Acidosis

3.3

6.4

3A422, ,

NOMESCO Finland

14.3

6.4

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.7

6.4

103

602

R31

ICD-10 Finland

Unspecified haematuria

1.3

6.4

410

3170

Z2445

NOMESCO Finland

Psychologist

1.7

6.4

104

610

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

2.8

6.4

113

ZXD00

NOMESCO Finland

Emergency procedure

2.0

6.3

315

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.1

6.3

J01MA02

ATC

ciprofloxacin; systemic

1.2

6.3

1470

13070

R4120

NOMESCO Finland

Occupational therapy

1.5

6.3

215

1496

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.8

6.3

537

FM1BD

NOMESCO Finland

Extensive CT of heart

5.9

6.3

TFP51

NOMESCO Finland

Ablation treatment of idiopathic left ventricle tachycardia

9.2

6.3

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.3

6.3

198

FM1CN

NOMESCO Finland

Heart perfusion isotope imaging at rest

18.0

6.3

ATB

Replacement of biventricular, physiological pacemaker DDD (R) S

+∞

6.2

C01DX22

ATC

vericiguat; systemic

+∞

6.2

354

Kela drug reimbursment

Ivabradine

+∞

6.2

ZXH02

NOMESCO Finland

Procedure performed inside intensive care unit

+∞

6.2

5244

FHL

Heart transplantation

+∞

6.2

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

6.2

459

3617

SPAT1283

SPAT

Restricted health certificate

1.4

6.2

338

2551

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

1.9

6.2

417

L14

ICPC

Leg/thigh symptom/complaint

1.4

6.1

267

1942

A10BJ05

ATC

dulaglutide; parenteral

2.0

6.1

312

G93.1

ICD-10 Finland

Anoxic brain damage, not elsewhere classified

5.7

6.1

K70.4

ICD-10 Finland

Alcoholic hepatic failure

3.2

6.1

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

1.8

6.1

461

Mitral valve plasty

7.7

6.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

6.1

1453

12939

XX3BW, ,

NOMESCO Finland

12.5

6.1

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.8

6.1

441

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

6.0

396

3070

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.1

6.0

247

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3502

11096

10.88

307.65

7.8

2.6

2419.38

1114.23

ng/l

28.78

3377

9324

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1122

2712

5.18

307.65

5.0

2.5

357.38

149.57

ng/l

27.71

1072

2449

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1893

5357

5.38

307.65

3.4

2.5

22.93

23.19

0.34

1816

4950

(3027456) Digoxin [Moles/volume] in Serum or Plasma

588

703

9.47

307.65

3.4

3.2

0.78

0.79

nmol/l

0.31

504

548

(3022948) Iron [Moles/volume] in Serum or Plasma

2011

6222

5.05

307.65

3.4

2.5

13.40

13.06

umol/l

1.07

1938

5759

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1958

5853

5.16

307.65

3.4

2.5

2.35

2.26

g/l

9.54

1873

5369

(3032080) INR in Blood by Coagulation assay

3101

18158

3.30

297.33

35.6

14.1

1.59

1.27

inr

121.03

2731

14998

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

501

905

6.10

268.46

2.2

2.0

11.53

12.21

mg/l

0.73

467

836

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2501

14030

2.77

239.03

5.7

3.1

34.76

40.25

ng/l

0.16

2134

10374

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1955

9758

2.78

233.96

3.0

2.3

3.10

2.81

mg/l

3.98

1740

8291

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2656

15812

2.67

217.97

4.2

2.9

188.48

160.03

ug/l

1.86

2520

14543

(3020779) Urea [Moles/volume] in Serum or Plasma

997

3595

3.28

212.75

14.1

6.5

12.00

9.78

mmol/l

12.88

961

3424

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

593

1529

4.31

207.87

2.2

1.9

34.23

39.83

u/l

5.51

423

1362

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1459

6604

2.79

206.19

6.2

3.4

0.81

mmol/l

0.04

1399

6206

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1444

6973

2.58

174.34

5.6

3.0

673.37

135.06

ng/l

1.04

1323

5585

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

492

1264

4.25

172.16

6.1

2.7

0.38

0.35

iu/ml

0.67

302

663

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1044

4469

2.74

159.00

13.9

7.3

5.08

5.13

kpa

0.83

1001

4313

(3027801) Oxygen [Partial pressure] in Arterial blood

1043

4470

2.74

158.42

13.9

7.3

11.46

12.47

kpa

9.01

998

4313

(3019977) pH of Arterial blood

1037

4455

2.72

156.57

14.0

7.3

7.42

0.06

527

2365

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2943

20239

2.32

150.15

9.8

7.1

14.11

12.39

umol/l

8.52

2848

19305

(3003396) Base excess in Arterial blood by calculation

1020

4435

2.68

149.66

14.1

7.2

0.86

0.90

mmol/l

0.10

860

3674

(3016502) Oxygen saturation in Arterial blood

943

3966

2.74

147.57

14.6

7.6

94.79

95.72

3.18

914

3837

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

727

2670

3.05

146.15

2.9

2.0

15.42

5.71

ug/l

5.29

653

2277

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1131

5250

2.54

144.46

8.9

5.7

1.08

1.02

mmol/l

9.76

1074

4877

(3023368) Bacteria identified in Blood by Culture

1944

11551

2.20

138.77

5.8

4.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

923

3950

2.68

138.76

5.6

3.6

5.90

5.81

kpa

1.56

894

3858

(3000991) Gas panel - Venous blood

840

3482

2.74

134.10

16.9

8.3

—

(3012544) pH of Venous blood

912

3964

2.63

132.30

5.7

3.6

7.37

7.38

1.53

512

2275

(3002032) Base excess in Venous blood by calculation

889

3843

2.64

130.21

5.6

3.6

1.75

1.87

mmol/l

0.38

783

3330

(3014111) Lactate [Moles/volume] in Serum or Plasma

850

3605

2.67

129.31

14.9

7.1

1.46

1.33

mmol/l

1.97

829

3543

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1032

4882

2.44

124.31

7.8

4.5

258.24

239.89

u/l

2.85

988

4629

(3013826) Glucose [Moles/volume] in Serum or Plasma

3092

22578

2.19

123.60

9.8

4.8

6.85

6.72

mmol/l

2.86

3007

21481

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1293

6790

2.27

122.06

2.2

1.9

—

(3001604) Monocytes [#/volume] in Blood

2737

19217

2.09

119.35

8.5

6.3

0.64

0.61

e9/l

8.28

2385

16227

(3002173) Hemoglobin [Mass/volume] in Arterial blood

841

3687

2.57

118.72

16.1

8.1

122.50

121.93

g/l

0.30

827

3601

(3006315) Basophils [#/volume] in Blood

2739

19278

2.08

118.10

8.5

6.3

0.04

e9/l

0.08

2382

16297

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2811

20034

2.08

116.34

13.3

7.0

1.20

1.21

mmol/l

28.16

2440

17198

(3013115) Eosinophils [#/volume] in Blood

2787

19810

2.07

116.07

9.0

6.6

0.19

e9/l

2.14

2448

16992

(3019198) Lymphocytes [#/volume] in Blood

2763

19600

2.07

115.41

8.6

6.4

1.74

1.90

e9/l

3.90

2439

16953

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2582

17941

2.03

113.36

12.7

6.4

1.20

1.21

mmol/l

23.99

2458

16456

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

518

1814

3.10

111.62

4.1

3.5

4.36

4.50

pmol/l

1.94

487

1603

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

644

2543

2.79

111.53

18.1

9.1

1.38

1.32

1.04

638

2530

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

624

2469

2.77

107.43

18.8

9.3

0.59

0.63

0.81

619

2457

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

592

2312

2.80

104.34

5.9

3.9

24.03

24.23

mmol/l

0.75

583

2290

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

609

2423

2.75

103.53

18.1

8.9

24.21

24.34

mmol/l

0.39

596

2379

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1091

5666

2.22

103.35

4.9

2.0

31.19

29.58

10.75

1063

5499

(42870588) Differential panel, method unspecified - Blood

2023

13246

1.96

101.38

8.9

6.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1328

7558

2.07

98.53

4.0

1.7

1.72

1.47

mg/l

1.26

1099

5874

(3019069) Monocytes/Leukocytes in Blood

2516

17859

1.93

97.67

9.1

6.7

9.21

9.10

1.01

2416

16647

(3024354) Oxygen [Partial pressure] in Venous blood

733

3281

2.47

97.48

4.9

3.1

4.57

4.56

kpa

0.02

707

3195

(3006504) Eosinophils/Leukocytes in Blood

2509

17810

1.93

97.20

9.0

6.6

2.63

2.86

5.91

2408

16594

(3002030) Lymphocytes/Leukocytes in Blood

2543

18199

1.92

95.34

9.0

6.6

24.06

27.01

33.52

2455

17147

(3022096) Basophils/Leukocytes in Blood

2502

17817

1.91

95.17

9.2

6.7

0.64

0.67

1.83

2403

16600

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

981

5053

2.20

93.74

2.1

1.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2874

21575

1.92

91.27

12.4

10.2

4.48

4.18

e9/l

8.85

2528

18493

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

492

1868

2.83

90.91

1.8

1.7

1.54

g/l

0.03

413

1604

(3018010) Neutrophils/Leukocytes in Blood

2484

17841

1.88

89.90

8.9

6.5

60.58

57.68

27.51

2412

16959

(3027945) Reticulocytes/Erythrocytes in Blood

926

4749

2.20

88.94

2.8

2.6

1.93

1.73

5.96

839

4193

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

910

4654

2.20

87.90

2.1

1.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

748

3587

2.30

84.18

2.6

2.7

64.35

66.24

g/l

7.63

705

3244

(3024561) Albumin [Mass/volume] in Serum or Plasma

2454

17902

1.82

80.92

6.6

5.2

34.12

35.27

g/l

18.68

2331

16688

(3042936) Bacteria identified in Isolate by Culture

1023

5678

2.04

78.66

2.6

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

323

1061

3.20

76.79

5.3

2.7

3.62

3.61

g/l

0.03

313

1012

(3018418) pH of Serum or Plasma

1775

11898

1.81

76.17

6.2

4.1

7.40

0.22

1325

8440

(3026493) Urate [Moles/volume] in Serum or Plasma

1570

10299

1.81

71.22

3.9

2.8

395.80

352.36

umol/l

37.74

1400

9040

(3020891) Body temperature

419

1679

2.65

69.06

5.9

4.3

36.90

36.92

°c

0.23

410

1659

(3023520) Reticulocytes [#/volume] in Blood

727

3716

2.14

68.79

2.8

2.6

71.81

66.88

e9/l

2.48

518

2707

(3003434) Protein [Mass/volume] in Pleural fluid

216

605

3.70

65.81

1.5

1.4

27.84

33.78

g/l

8.92

183

559

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3517

29450

1.90

65.78

12.8

8.5

81.35

80.87

u/l

0.26

3400

27851

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

577

2736

2.27

65.62

5.8

3.8

5.28

5.16

kpa

2.25

554

2594

(3021589) Normoblasts [#/volume] in Blood

2251

16621

1.71

65.52

18.4

11.5

0.00

e9/l

0.22

1847

13435

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

501

2253

2.38

64.40

20.7

9.2

16.03

16.11

0.22

485

2176

(3004119) Hemoglobin [Mass/volume] in Venous blood

518

2375

2.33

63.67

5.0

2.9

128.99

130.80

g/l

0.89

493

2320

(3026250) Tacrolimus [Mass/volume] in Blood

138

7.08

63.41

39.7

42.2

7.81

7.12

ug/l

2.13

132

(3008152) Bicarbonate [Moles/volume] in Arterial blood

491

2218

2.36

62.39

9.6

6.5

24.56

24.62

mmol/l

0.10

466

2128

(3042733) HLA Ab [Presence] in Serum

100

8.33

62.38

5.5

4.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

501

2302

2.32

61.16

5.4

3.7

2.41

1.77

mmol/l

2.78

380

1691

(3009343) pH of Capillary blood

553

2649

2.24

61.13

5.9

3.8

7.41

7.42

0.48

481

2170

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1687

11763

1.69

58.82

2.7

2.1

210.46

219.98

u/l

0.19

1602

11117

(3037522) Nuclear Ab [Titer] in Serum

820

4627

1.94

58.16

1.4

1.3

472.39

500.86

titre

0.16

163

955

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

284

1016

2.91

57.93

5.7

2.6

220.63

197.09

3.94

278

962

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

300

1112

2.82

57.30

6.9

2.3

89.29

91.42

0.86

294

1083

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

388

1640

2.49

56.93

2.1

1.9

5.72

2.73

ug/l

0.37

343

1429

(3033658) Prothrombin time (PT) actual/Normal

1477

10009

1.71

56.79

6.6

4.3

72.81

87.71

68.66

1452

9814

(3009445) Proteinase 3 Ab [Units/volume] in Serum

384

1645

2.46

54.68

1.5

15.78

15.77

iu/ml

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

301

1152

2.73

54.03

1.8

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

728

4046

1.95

53.62

2.2

2.4

0.19

0.21

g/l

4.91

672

3772

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

348

1440

2.53

53.33

3.3

3.4

49.37

50.92

mg/l

0.05

288

1243

(3023199) Leukocytes [#/volume] in Pleural fluid

183

529

3.56

53.14

1.5

1.4

9426.31

2297.40

e6/l

0.66

121

370

(3034860) Kappa light chains.free [Mass/volume] in Serum

348

1444

2.53

53.02

3.3

3.4

60.17

53.54

mg/l

0.31

290

1244

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

338

1388

2.55

52.62

1.3

1.2

—

(3024932) HLA-DR beta [Type]

7.79

52.62

1.1

—

(3044889) 12 lead EKG panel

3152

26211

1.68

52.31

7.8

3.8

0.50

6646.10

—

(3024471) HLA-A [Type]

7.71

52.15

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

189

565

3.45

52.12

8.1

6.2

11.67

11.80

mg/l

0.15

178

529

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

268

987

2.82

51.74

1.7

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

269

1008

2.77

50.24

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

258

953

2.81

49.51

5.4

3.6

8.20

8.13

kpa

0.25

252

927

(3036489) Thrombin time

327

1363

2.51

49.27

5.4

2.1

21.52

20.98

0.79

315

1234

(3024928) Oxygen saturation in Venous blood

257

956

2.79

48.66

5.5

2.8

62.92

60.94

0.69

245

932

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1688

12209

1.61

48.38

3.9

3.4

44.84

36.18

u/l

1.30

1594

11459

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

312

1284

2.53

48.28

3.1

3.3

11.96

3.42

ratio

0.53

163

741

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

196

633

3.19

47.71

1.6

1.3

238.13

270.94

u/ml

1.06

144

382

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

331

1410

2.45

47.56

4.1

2.1

442.32

654.75

ug/l

0.66

321

1342

(3012441) Differential panel - Pleural fluid

163

473

3.54

47.05

1.6

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

243

894

2.81

46.96

2.8

2.9

32.81

35.30

umol/l

0.72

227

800

(3022493) Free Hemoglobin [Mass/volume] in Plasma

141

5.97

46.69

25.2

1.4

97.34

71.78

mg/l

0.51

(3018405) Lactate [Moles/volume] in Arterial blood

286

1148

2.59

46.58

5.5

3.9

1.44

1.38

mmol/l

0.42

280

1138

(3027273) Bicarbonate [Moles/volume] in Venous blood

377

1717

2.30

46.55

4.4

3.0

25.04

25.26

mmol/l

0.50

362

1662

(3044640) Blood type and Crossmatch panel - Blood

1699

12411

1.59

46.11

3.4

2.5

—

(1616796) Gas panel - Central venous blood

225

810

2.87

45.26

5.0

3.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

204

696

3.02

45.20

1.5

1.2

—

41.12

—

(3045788) Cell count panel - Pleural fluid

150

425

3.61

44.88

1.6

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

399

1890

2.22

44.78

4.8

3.6

48.13

47.58

0.17

393

1865

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

191

633

3.10

44.50

1.8

1.4

145.73

150.59

au/ml

0.22

200

(40767503) Oxygen content in Capillary blood by calculation

210

739

2.93

44.03

3.6

2.6

16.55

16.35

0.38

210

723

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

203

701

2.98

44.03

1.8

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

100

6.88

44.00

2.7

2.4

225.10

164.73

4.07

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

409

1971

2.18

43.96

1.5

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3168

26985

1.59

41.63

5.0

4.0

15.57

14.89

pmol/l

37.38

2936

24355

(3028308) Erythrocytes [#/volume] in Pleural fluid

156

482

3.31

40.82

1.5

1.4

28446.02

70091.35

e6/l

1.32

264

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

693

4116

1.81

40.55

1.8

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

105

249

4.29

40.27

1.6

1.5

14.77

13.37

umol/l

1.25

105

228

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

195

693

2.89

40.15

1.7

1.8

—

(3012501) Base excess in Blood by calculation

203

742

2.82

39.68

4.8

4.3

2.73

2.57

mmol/l

0.29

142

506

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1640

12193

1.54

39.52

3.5

2.7

57.32

70.48

u/l

1.22

1556

11269

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

520

2841

1.94

39.51

1.7

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

735

4475

1.77

39.45

2.2

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

461

2422

2.01

39.21

1.5

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1340

9540

1.58

39.07

3.3

2.5

—

(40768806) Pleura Pathology biopsy report

150

465

3.30

39.05

1.5

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

613

3555

1.84

38.66

1.8

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

1759

13324

1.53

38.64

4.1

3.5

146.40

82.29

e6/l

0.43

1394

10165

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

119

319

3.80

38.63

2.4

17.37

29.02

iu/ml

0.79

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

276

1192

2.40

38.35

5.0

3.6

1.93

1.51

mg/l

10.05

260

1073

(3036782) Glucose [Moles/volume] in Pleural fluid

140

423

3.38

37.97

1.4

1.3

6.45

6.14

mmol/l

0.74

131

395

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

483

2612

1.95

37.74

1.9

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

149

5.24

37.73

32.7

24.2

126.84

117.29

ug/l

0.46

123

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

154

498

3.16

37.40

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

524

2921

1.90

37.36

5.6

3.8

115.91

85.37

ng/l

8.80

468

2475

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

130

5.53

36.96

5.3

2.4

17.10

82.18

ug/l

0.54

115

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

210

822

2.63

35.93

9.4

5.1

745.22

2358.50

iu/ml

0.38

114

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

148

480

3.15

35.78

1.5

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

155

526

3.01

34.67

1.5

1.2

3.54

3.71

u/ml

0.08

257

(3048929) Epstein Barr virus Ab [Presence] in Serum

228

946

2.48

34.56

1.5

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2168

17408

1.47

34.43

3.6

2.8

—

estimate

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

220

906

2.50

33.88

2.9

2.2

132.23

129.38

g/l

0.76

156

666

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

704

4421

1.70

33.35

2.9

10.22

9.77

umol/l

0.22

634

3931

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

154

535

2.94

33.05

1.5

1.2

2.05

3.91

u/ml

1.59

196

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

209

850

2.53

33.05

1.5

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1526

11503

1.49

32.87

4.0

3.4

0.69

0.43

e6/l

2.96

1160

8419

(3005719) IgG [Mass/volume] in Serum or Plasma

495

2826

1.84

32.54

3.1

2.9

10.61

10.58

g/l

0.03

462

2585

(46235355) HIV 1 and 2 tests - Meaningful Use set

759

4902

1.66

32.23

1.9

1.7

—

(3018095) Leukocytes [#/volume] in Urine

1866

14757

1.45

30.89

4.9

4.1

103.96

93.15

e6/l

0.22

1405

10572

(3022313) Gas panel - Capillary blood

368

1941

1.97

30.73

6.5

3.9

—

(40758558) Short blood count panel - Blood

1508

11466

1.47

30.55

9.9

6.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

178

698

2.61

30.35

1.3

1.2

151.11

425.66

titre

—

(3000850) Epithelial cells [#/volume] in Urine

1252

9184

1.50

30.27

3.3

2.7

4.56

4.45

e6/l

0.14

1166

8374

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

230

1018

2.33

30.18

1.9

1.6

1.16

1.19

g/l

0.54

216

967

(3028026) IgM [Mass/volume] in Serum or Plasma

400

2184

1.91

30.14

1.9

2.0

1.36

1.38

g/l

0.05

373

1980

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

140

487

2.93

30.00

1.4

1.1

93.13

115.32

8.85

135

446

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

727

2.56

29.88

1.5

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

639

4027

1.68

29.61

4.5

3.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

223

982

2.34

29.61

1.9

1.6

0.23

0.24

g/l

0.20

208

934

(3026008) Bacteria identified in Urine by Culture

1484

11302

1.47

29.59

3.5

3.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

141

498

2.89

29.39

1.3

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

214

932

2.36

29.14

1.6

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

344

1807

1.98

29.03

2.3

3.73

g/l

0.01

322

1632

(4195642) Thrombophilia screening test

135

469

2.93

29.00

1.4

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

113

356

3.23

28.71

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

344

1814

1.97

28.70

2.3

7.20

7.31

g/l

0.56

323

1634

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

344

1815

1.97

28.66

2.3

4.09

4.19

g/l

1.77

323

1641

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

128

437

2.98

28.37

1.4

1.3

639.48

365.89

u/l

0.33

120

418

(3031040) Bacteria [#/volume] in Urine by Automated count

2858

24663

1.44

28.18

5.4

4.7

1561.22

2168.78

e6/l

0.24

353

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

7.70

28.00

6.1

7.3

5.92

5.78

kpa

0.36

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

251

1195

2.16

27.60

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

326

1711

1.97

27.56

2.3

3.04

2.88

g/l

2.15

304

1537

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

208

917

2.33

27.54

1.7

1.5

—

(4268621) Lupus anticoagulant assay

113

366

3.14

27.43

3.0

2.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

219

998

2.25

26.83

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

294

1507

2.02

26.56

3.0

2.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1509

11708

1.43

26.55

2.0

1.7

18.94

20.12

nmol/l

2.36

1301

9834

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

171

703

2.49

26.45

1.3

1.2

176.00

112.00

titre

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3133

27651

1.44

26.16

5.7

4.3

15.77

12.45

mm/h

20.90

2961

25704

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

266

1323

2.07

26.10

2.2

2.3

0.01

0.03

g/l

0.82

240

1181

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

158

636

2.54

25.56

4.7

2.9

368.18

3036.15

u/ml

1.34

(3009508) Creatinine [Moles/volume] in Urine

1711

13648

1.41

25.47

3.8

3.5

7.19

7.87

mmol/l

8.57

1444

11414

(44816559) Phosphatidylethanol [Mass/volume] in Blood

295

1543

1.97

25.16

1.8

1.7

0.43

0.32

mg/l

2.01

163

755

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

292

1525

1.98

25.01

6.5

4.1

25.10

24.81

mmol/l

0.82

272

1392

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

6.77

25.00

1.5

1.4

78.50

88.57

0.72

(3019309) Folate [Moles/volume] in Red Blood Cells

970

6985

1.49

24.88

1.8

1223.61

1127.37

nmol/l

2.10

767

5146

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

300

1590

1.95

24.61

2.7

2.4

0.55

0.96

g/l

1.69

260

1349

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3634

33132

1.51

24.57

6.3

4.9

2.12

1.96

mu/l

3.48

3409

30125

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

6.83

24.57

1.5

1.3

79.48

87.61

0.47

(44790048) Parainfluenza type 2 nucleic acid detection

127

468

2.76

24.51

1.6

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

127

468

2.76

24.51

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

127

468

2.76

24.51

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

127

468

2.76

24.51

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

201

918

2.24

24.50

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1669

13324

1.40

24.44

4.7

4.2

11.07

7.98

mg/mmol

2.06

1168

8330

(3038071) Oxygen [Partial pressure] in Mixed venous blood

7.60

24.16

5.6

7.7

5.34

5.77

kpa

0.41

(36304419) Bacteria [Presence] in Urine

1403

10897

1.42

23.96

3.9

3.3

0.33

52.14

estimate

—

(3012516) Albumin [Mass/volume] in Urine

1636

13077

1.39

23.53

3.9

3.5

66.53

45.09

mg/l

2.59

1162

8425

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

252

1278

2.03

23.44

2.3

0.00

g/l

0.79

220

1108

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

290

1550

1.93

23.20

2.3

10.20

10.27

g/l

0.09

265

1360

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3892

36122

1.58

23.16

30.7

16.3

25.24

27.12

mg/l

3.72

3605

29844

(3025159) Blasts/Leukocytes in Blood

529

3377

1.64

22.98

5.4

4.7

0.11

0.24

0.62

172

963

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

309

1693

1.88

22.92

6.8

4.7

1.62

1.59

0.28

294

1599

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

102

352

2.94

22.24

1.2

1.3

15.33

13.07

u/l

0.19

327

(40760892) CBC W Ordered Manual Differential panel - Blood

1048

7808

1.45

22.22

5.9

4.9

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.21

22.15

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

172

768

2.29

22.14

1.4

1.3

17.99

35.05

u/l

2.87

155

662

(3034426) Prothrombin time (PT)

106

4.75

22.14

1.6

1.3

29.76

28.48

0.54

106

(3035880) pH of Pleural fluid

225

3.46

22.12

1.3

1.2

7.41

7.40

0.01

149

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

479

3012

1.66

22.04

3.5

2.6

54.84

67.07

ml/min/173m2

10.29

254

1215

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

492

3116

1.65

22.01

5.2

3.8

1.21

1.23

mmol/l

5.91

451

2672

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

164

720

2.32

21.96

1.4

—

(3026782) Osmolality of Urine

1054

7898

1.44

21.56

3.5

2.9

517.62

551.31

mosm/kgh2o

6.12

951

6932

(3002179) Metamyelocytes/Leukocytes in Blood

523

3382

1.62

21.50

5.2

4.3

0.78

0.71

0.21

195

1117

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

187

3.67

21.40

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

232

1184

2.01

21.21

2.3

0.00

g/l

-0.00

219

1105

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

6.99

21.16

1.2

1.1

58.49

1897.29

ng/l

0.49

(3021440) Promyelocytes/Leukocytes in Blood

519

3372

1.61

20.90

5.3

4.5

0.11

0.13

0.45

179

1010

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

292

1620

1.86

20.82

2.4

2.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

112

4.50

20.73

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

108

400

2.74

20.69

2.2

2.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

140

591

2.41

20.50

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

257

3.19

20.43

1.5

1.2

90.14

81.65

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

163

3333

0.47

20.40

1.7

2.1

4.04

3.66

ratio

2.44

131

2666

(40757494) Bilirubin.total [Moles/volume] in Blood

164

3.75

19.85

2.2

26.33

23.27

umol/l

—

(3052851) Hemolysis interference index of Serum or Plasma

208

1050

2.03

19.61

4.5

3.3

2.75

2.10

index

0.57

114

551

(3011335) Digoxin [Mass/volume] in Serum or Plasma

8.16

19.60

2.2

1.9

0.65

0.69

ug/l

0.15

(3017181) Myelocytes/Leukocytes in Blood

532

3529

1.57

19.56

5.3

4.4

0.91

1.01

0.37

193

1161

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

168

784

2.19

19.46

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

168

784

2.19

19.46

1.4

1.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

175

838

2.13

19.00

1.7

1.9

178.55

11.30

iu/l

0.70

315

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

269

1498

1.84

18.94

2.1

1.9

—

(3023420) DNA double strand Ab [Units/volume] in Serum

251

1375

1.87

18.62

1.7

10.12

7.68

iu/ml

0.54

316

(3020876) Protein [Mass/time] in 24 hour Urine

122

506

2.45

18.60

2.1

2.4

1.42

1.18

g/24h

0.37

298

(3036481) Cortisol [Moles/volume] in Serum or Plasma

505

3355

1.57

18.40

2.7

2.5

386.27

379.76

nmol/l

0.29

481

3102

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

306

2.88

18.39

1.5

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

204

3.32

18.11

2.1

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

269

1531

1.80

17.65

7.2

4.9

0.81

0.87

1.72

253

1443

(3015377) Calcium [Moles/volume] in Serum or Plasma

1659

13733

1.33

17.57

4.2

3.7

2.34

2.35

mmol/l

2.78

1501

12397

(3029937) Albumin [Presence] in Urine by Test strip

1365

10988

1.35

17.46

4.7

3.9

0.00

estimate

0.11

475

3724

(3007164) IgA [Mass/volume] in Serum or Plasma

891

6707

1.41

17.25

1.7

1.5

2.81

2.56

g/l

1.86

586

3979

(3037756) Immunofixation for Serum or Plasma

180

912

2.01

16.83

1.5

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2084

17888

1.31

16.72

2.4

2.2

93.36

94.12

pmol/l

0.31

1216

9611

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

124

3.90

16.57

1.8

2.1

7132.63

1924.38

e6/l

1.59

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

209

1126

1.90

16.34

1.5

1.4

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

109

2373

0.45

16.10

1.5

1.8

3.58

3.54

mmol/l

0.14

1691

(3006576) Bicarbonate [Moles/volume] in Blood

4.76

16.07

6.9

6.1

25.87

24.31

mmol/l

1.16

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

285

2.80

15.99

1.1

1.2

295.00

144.47

titre

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

336

2.65

15.97

1.4

12.13

12.37

u/l

0.14

326

(3005532) Lymphocytes/Leukocytes in Pleural fluid

152

3.51

15.75

1.4

1.3

71.38

65.28

0.65

125

(3004451) EKG impression Narrative

131

3.69

15.36

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

327

2.63

15.22

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

327

2.63

15.22

1.8

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

327

2.63

15.22

1.8

1.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

4.15

15.06

5.1

8.1

71.31

72.67

0.12

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

413

2.43

14.97

1.8

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

417

2777

1.55

14.94

1.6

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

183

974

1.91

14.87

1.2

1.3

75.00

146.35

titre

1.36

(3017569) Oxygen content in Arterial blood

209

3.04

14.84

2.5

2.3

16.51

16.09

0.35

209

(3026692) Albumin [Mass/volume] in Peritoneal fluid

109

3.88

14.44

1.4

1.7

16.35

10.79

g/l

3.98

(21494755) Public health laboratory ask at order entry panel

147

2772

0.51

14.33

1.3

1.4

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

110

3.84

14.26

1.3

18.95

22.26

0.29

104

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

875

6761

1.36

14.14

3.6

3.3

2.79

1.82

e6/l

1.89

433

3307

(3000012) Reticulocyte production index

123

581

2.15

13.92

2.5

2.2

0.93

0.86

0.55

384

(3019550) Sodium [Moles/volume] in Serum or Plasma

3960

37596

1.45

13.91

43.0

19.0

139.45

139.68

mmol/l

7.25

3928

36799

(3000494) Fungus identified in Specimen by Culture

643

4739

1.42

13.78

1.7

1.5

—

(3042631) Mycobacterium sp identified in Specimen

122

577

2.14

13.76

2.7

2.6

—

(3014891) Appearance of Pleural fluid

6.24

13.71

1.8

1.4

—

(1761868) Lipid panel - Serum or Plasma

1073

13153

0.76

13.66

3.4

3.2

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

+∞

13.54

1.2

0.0

38.08

—

ng/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

125

604

2.10

13.35

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

386

2.38

13.31

1.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

406

2.34

13.21

5.7

21.2

7.45

7.17

mmol/l

0.32

338

(3023103) Potassium [Moles/volume] in Serum or Plasma

3961

37686

1.43

12.98

43.4

19.2

4.07

3.99

mmol/l

65.47

3930

36825

(3047181) Lactate [Moles/volume] in Blood

191

1079

1.80

12.89

7.6

5.6

1.36

1.29

mmol/l

0.29

168

948

(3021601) Nitrite [Presence] in Urine by Test strip

2233

19723

1.26

12.87

4.5

3.8

0.00

estimate

1.08

547

4121

(3001893) Eosinophils/Leukocytes in Pleural fluid

128

3.46

12.86

1.4

1.3

3.65

2.01

0.73

109

(3023487) Leukocytes [#/volume] in Peritoneal fluid

148

3.26

12.81

1.9

2.2

1024.89

657.29

e6/l

0.30

101

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

922

7277

1.33

12.81

3.5

3.2

1.22

1.01

e6/l

0.74

478

3848

(43055442) Apixaban [Mass/volume] in Serum or Plasma

4.70

12.79

1.6

1.4

66.21

134.24

ug/l

3.04

(3016650) Hepatitis A virus Ab [Presence] in Serum

118

568

2.10

12.75

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

2266

20069

1.26

12.68

4.5

3.8

0.02

0.09

estimate

0.43

491

3976

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

142

734

1.96

12.62

1.3

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1110

9015

1.31

12.54

4.3

3.7

0.33

0.16

0.29

114

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

+∞

12.50

1.2

0.0

—

(3035350) Ketones [Presence] in Urine by Test strip

2251

19943

1.26

12.47

4.5

3.8

5.10

4.54

estimate

0.05

560

4244

(3000475) Leukocytes [#/volume] in Synovial fluid

187

1063

1.79

12.38

1.7

1.6

19572.77

16569.11

e6/l

0.24

128

730

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

230

2.72

12.00

1.5

1.6

—

(40768446) Kidney Pathology biopsy report

145

3.19

11.87

1.5

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

237

2.68

11.87

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

209

2.80

11.86

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

209

2.80

11.86

1.5

1.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

256

2.60

11.71

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

122

616

2.01

11.62

1.8

2.0

4.55

4.79

mmol/24h

0.33

106

531

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

512

3749

1.41

11.28

2.7

2.6

37.00

53.22

u/l

0.65

429

3199

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3726

35259

1.33

11.25

32.8

16.2

71.59

78.53

ml/min/173m2

61.57

3579

32714

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

112

558

2.03

11.09

1.2

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

210

2.69

10.65

2.0

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

210

2.69

10.65

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

210

2.69

10.65

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

210

2.69

10.65

2.0

1.9

—

(4035726) Immunohistochemistry procedure

497

3657

1.40

10.63

1.7

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1238

10375

1.27

10.61

1.4

1.3

—

(3003181) Sodium [Moles/volume] in Urine

137

748

1.86

10.39

1.4

1.3

60.78

62.69

mmol/l

0.21

106

607

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

4.28

10.27

1.3

8.00

6.86

0.12

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

101

502

2.03

10.10

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

372

2.20

9.94

1.4

1.3

137650.51

80654.46

e6/l

0.36

248

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1048

0.36

9.91

1.1

0.64

0.65

ratio

—

135

(3023383) Lactate [Moles/volume] in Pleural fluid

146

2.96

9.84

1.3

2.30

3.34

mmol/l

2.74

137

(40761536) Microorganisms panel - Urine sediment

411

2970

1.42

9.74

5.0

3.9

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

111

3.26

9.68

1.4

24.02

23.86

0.01

(3030981) Hyaline casts [#/volume] in Urine by Automated count

464

3430

1.39

9.64

2.7

2.5

0.58

0.49

e6/l

0.38

449

3298

(3051611) Lipemic interference index of Serum or Plasma

385

2.15

9.54

5.4

3.0

13.70

11.95

index

0.51

214

(3014765) Yersinia sp identified in Stool by Organism specific culture

155

903

1.74

9.51

1.2

—

(3044007) Cell count panel - Peritoneal fluid

130

3.01

9.24

2.1

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

951

11378

0.79

9.14

3.1

3.4

0.84

0.79

ug/l

0.36

692

7622

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2204

19880

1.21

9.02

2.7

2.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

152

897

1.72

8.93

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

12.53

8.85

3.3

12.4

111.40

102.00

g/l

0.99

(42529406) Shigella sp [Presence] in Stool by Culture

153

908

1.71

8.81

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1105

0.41

8.81

1.2

1.37

1.48

g/l

2.92

1105

(3027135) IgG subclass 1 [Mass/volume] in Serum

345

2.16

8.80

1.2

1.4

7.20

6.79

g/l

0.41

253

(3025941) Bacteria identified in Stool by Culture

259

1750

1.51

8.70

1.3

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

368

2.11

8.61

1.1

1.2

115.00

66.66

u/l

0.63

318

(3044242) Glucose [Moles/volume] in Arterial blood

216

2.47

8.59

1.9

2.2

8.02

8.04

mmol/l

0.01

216

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

205

2.50

8.51

1.2

1.3

26.66

22.77

u/l

0.37

167

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

973

8105

1.25

8.49

1.8

1.7

12219911.07

25884552.88

pmol/l

0.51

802

6645

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

3.80

8.49

1.0

1.1

1050.00

778.57

titre

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

345

2.13

8.41

1.2

1.4

0.47

0.39

g/l

1.01

252

(3028192) IgG subclass 2 [Mass/volume] in Serum

346

2.13

8.35

1.2

1.4

3.21

2.92

g/l

0.61

253

(4062490) Immunoglobulin typing, IgG

340

2.13

8.31

1.2

1.4

—

(3017732) Neutrophils [#/volume] in Blood

612

4825

1.31

8.28

3.5

3.4

4.78

4.73

e9/l

0.07

522

4057

(3015736) pH of Urine

1779

15806

1.21

8.28

4.0

3.3

6.22

6.21

0.19

871

8685

(3023419) Bacteria identified in Sputum by Culture

527

1.90

8.20

2.2

2.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

174

1089

1.62

8.20

1.3

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.21

8.18

1.6

1.2

30.69

22.58

g/l

3.03

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

210

2.44

8.11

1.2

1.3

101.12

91.15

u/l

0.27

174

(3037121) Protein [Mass/volume] in Urine

213

1403

1.54

8.07

3.4

3.5

524.11

387.10

mg/l

0.29

125

676

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

178

1125

1.60

8.06

1.7

1.5

0.09

4.18

iu/ml

0.68

193

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.52

7.94

1.3

1.2

0.71

1.85

mmol/l

0.68

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1153

0.45

7.92

1.3

1.2

0.90

0.91

g/l

0.03

1153

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1891

16948

1.20

7.89

2.8

2.4

75.87

78.11

nmol/l

2.44

1706

15096

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

6.57

7.86

3.1

2.2

52.38

56.26

0.14

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

3.78

7.77

1.3

1.2

25.85

611.76

u/l

0.58

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1306

14903

0.82

7.70

3.9

4.6

22.37

21.81

0.62

643

7612

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.53

7.67

1.5

1.6

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

338

2.09

7.66

2.0

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.27

7.63

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

389

1.99

7.47

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

140

855

1.66

7.31

1.2

—

25.16

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

185

1210

1.55

7.27

1.3

1.2

0.11

0.58

u/ml

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.30

7.22

1.7

1.2

1.15

1.17

mmol/l

0.43

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3626

34641

1.24

7.21

7.6

6.4

41.14

39.28

mmol/mol

27.18

3416

31988

(3019225) pH of Specimen

516

4055

1.31

7.12

6.0

4.4

7.38

7.36

1.48

424

2859

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

964

8164

1.23

7.08

3.2

3.3

2.47

2.46

mmol/l

1.66

863

7324

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.05

7.06

10.5

12.0

5.08

5.86

mmol/l

0.62

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.09

6.99

1.1

1.2

65.33

89.67

2.38

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3529

33659

1.22

6.89

4.9

4.2

1.41

1.30

mmol/l

12.66

3277

30358

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

5.82

6.89

6.9

6.0

11.41

10.45

0.71

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

3.05

6.86

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

367

1.98

6.84

3.5

3.1

—

(3039000) Anion gap in Blood by calculation

122

734

1.68

6.77

10.1

6.8

11.50

11.28

mmol/l

0.24

109

654

(3018572) Chloride [Moles/volume] in Blood

122

734

1.68

6.77

10.1

6.8

104.85

104.70

mmol/l

0.10

109

654

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

110

2.83

6.66

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

316

2.04

6.65

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

538

4292

1.29

6.62

1.8

1.71

1.51

5.06

460

3708

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

730

6050

1.25

6.52

1.3

49.13

35.94

iu/ml

0.95

222

1774

(3006571) Granulocytes/Leukocytes in Synovial fluid

445

1.86

6.49

1.5

65.28

58.88

0.73

277

(3047189) Immunofixation for 24 hour Urine

189

2.34

6.45

1.8

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.98

6.36

1.1

1.4

55.72

89.37

3.18

(3019832) Treponema pallidum Ab [Presence] in Serum

247

1766

1.42

6.27

1.6

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

503

1.78

6.20

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

489

1.79

6.17

1.3

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

103

608

1.71

6.17

1.5

1.7

0.79

0.89

g/l

0.32

487

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.66

6.11

2.6

3.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

195

1342

1.47

6.07

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2615

24409

1.17

6.02

4.3

3.4

74.10

52.90

u/l

13.21

2462

22708

(3024522) Salmonella sp identified in Specimen by Organism specific culture

494

1.77

5.98

1.3

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

126

794

1.60

5.88

1.2

1.60

3.83

u/ml

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

311

1.97

5.85

1.1

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

160

1066

1.52

5.85

5.5

1.7

6.51

4.70

mg/l

0.73

147

791

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3116

29529

1.18

5.83

38.3

20.3

14.27

13.68

79.91

3102

29085

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

411

1.84

5.80

1.1

3.65

3.17

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

326

1.94

5.79

1.1

1.4

30.24

30.29

0.00

193

(3005322) IgE [Units/volume] in Serum or Plasma

283

2100

1.37

5.79

1.4

1.3

350.71

294.41

u/ml

0.18

270

1945

(3017446) Testosterone [Moles/volume] in Serum or Plasma

363

4648

0.76

5.78

2.5

2.3

12.00

13.69

nmol/l

3.31

324

4215

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

187

2655

0.69

5.75

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

134

863

1.57

5.71

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

120

755

1.60

5.65

3.6

3.9

1.74

1.57

0.17

107

666

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

274

2.02

5.64

2.7

2.3

—

(3036603) Volume of Urine

295

1.98

5.61

1.4

1.7

2002.05

1922.19

0.28

289

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

158

2.35

5.54

1.5

1.8

75.00

121.41

umol/l

0.89

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

134

870

1.56

5.53

2.1

2.2

132.37

91.70

ug/min

0.48

495

(3006922) Hepatitis E virus Ab [Presence] in Serum

277

2.00

5.48

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

545

1.70

5.48

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

472

1.75

5.41

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

473

1.75

5.38

1.3

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

142

2.40

5.36

1.2

0.64

0.44

g/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.73

5.35

1.0

1.1

25.25

20.86

u/l

—

(3036525) Urea [Moles/time] in 24 hour Urine

7.87

5.33

3.3

2.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

161

2.31

5.33

2.3

2.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.79

5.28

1.3

1.2

1.36

1.80

mmol/l

1.28

(3025468) Yersinia sp identified in Specimen by Organism specific culture

470

1.74

5.22

1.3

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1031

0.54

5.21

1.8

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

134

2.40

5.03

2.4

1.6

82.57

53.99

ug/l

1.04

129

(3011412) CD3 cells [#/volume] in Blood

372

1.81

5.02

2.8

2.4

888.47

1144.62

e6/l

2.27

333

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3648

35173

1.20

5.02

6.0

5.2

6.25

5.99

mmol/l

20.45

3373

31872

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

160

2.26

4.96

2.3

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

160

2.26

4.96

2.3

2.1

—

(21494434) Karyotype in Bone marrow

374

1.80

4.94

1.1

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

6.01

4.90

1.3

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.67

4.89

1.4

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

443

1.73

4.84

5.7

4.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

140

948

1.49

4.80

1.3

4.31

6.25

u/ml

0.40

143

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

284

1.91

4.80

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

139

943

1.49

4.73

1.3

1.2

2.47

2.88

u/ml

0.20

(3027923) C peptide [Moles/volume] in Serum or Plasma

203

2.08

4.72

1.3

1.43

1.16

nmol/l

0.57

149

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

101

639

1.59

4.71

1.1

—

0.96

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

548

4559

1.23

4.68

12.8

6.3

—

(3049717) Cytology report of Urine Cyto stain

240

1798

1.35

4.68

2.7

2.9

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

260

1.93

4.61

2.4

0.51

0.60

e9/l

0.85

251

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

310

1.85

4.59

1.1

1.0

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

283

1.88

4.52

2.3

16.19

15.37

0.19

272

(3043410) Blood group antigens tested for on Red Blood Cells

2.65

4.47

1.8

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

108

704

1.55

4.45

1.6

—

(40768795) Lymph node Pathology biopsy report

411

1.71

4.38

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

189

2.07

4.38

4.1

3.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

427

1.70

4.35

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

107

701

1.54

4.32

1.3

170.77

206.54

miu/ml

0.40

263

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

863

7544

1.18

4.31

1.3

1.55

2.01

u/ml

0.58

208

1891

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

2.36

4.30

3.8

2.4

4.95

4.91

kpa

0.04

119

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

119

2.36

4.30

3.8

2.4

9.93

10.40

kpa

0.44

119

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

118

792

1.50

4.27

1.1

2.19

4.13

—

101

(3047007) Chlamydophila sp Ab [Presence] in Serum

415

1.70

4.25

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

438

1.68

4.24

1.3

0.19

nmol/l

0.05

358

(3012565) Volume of 24 hour Urine

172

2.10

4.21

1.9

2.4

1807.10

2062.98

0.75

147

(4034850) Laboratory test

151

1068

1.43

4.18

19.7

9.2

—

(3045142) Bone marrow Pathology biopsy report

495

1.63

4.13

1.3

—

(40768797) Stomach Pathology biopsy report

610

5195

1.20

4.11

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

141

2.20

4.10

2.3

2.9

0.63

0.60

mmol/l

0.81

141

(3037692) Legionella sp identified in Specimen by Organism specific culture

155

2.14

4.04

1.6

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.67

3.98

1.2

2.0

6.92

7.98

mmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1596

14664

1.14

3.96

4.6

3.8

0.01

0.21

estimate

0.77

441

3408

(3014271) Vancomycin [Susceptibility]

220

1.92

3.85

3.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

243

1.86

3.77

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

188

1.97

3.71

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

188

1.97

3.71

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

123

863

1.44

3.61

1.3

—

(3045424) Erythrocytes [Presence] in Urine

257

2024

1.28

3.58

2.3

2.1

0.00

0.03

estimate

0.81

575

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

430

1.61

3.52

3.7

3.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

441

1.60

3.43

1.7

2.4

429.94

3859.18

u/l

2.04

167

(3001019) Free T4 and TSH panel - Serum or Plasma

1283

0.67

3.40

1.5

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

153

2.03

3.39

2.3

2.1

31.97

34.24

0.39

153

(3044927) Protein electrophoresis panel - Urine

435

1.59

3.37

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

497

4235

1.19

3.34

2.3

2.5

143.62

146.63

ug/g

0.08

386

3392

(3045414) Leukocytes [Presence] in Urine

446

3763

1.20

3.34

2.3

2.1

0.00

0.01

estimate

1.05

738

(37208534) Antinuclear antibody arbitrary concentration in serum

102

2.26

3.28

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

219

1.83

3.25

1.5

4.24

7.47

u/l

1.39

172

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

368

0.41

3.25

1.0

1.4

171.19

192.22

pmol/l

0.23

368

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.03

3.24

2.2

1.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.80

3.18

1.1

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

259

1.74

3.12

2.8

2.5

395.81

530.74

e6/l

1.13

215

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

260

1.74

3.08

3.0

2.6

203.18

238.04

e6/l

0.67

226

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

5.00

3.04

1.5

5.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

495

1.52

3.04

4.6

3.8

57.95

56.73

0.20

422

(4281824) Cell count and differential, peritoneal fluid

346

1.62

3.01

1.5

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

240

1.76

3.00

1.8

1.4

98.07

90.40

umol/l

0.63

240

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3966

38844

1.18

2.97

43.8

21.4

95.30

80.83

umol/l

63.10

3940

38312

(1002224) Polysomnography panel

123

1661

0.73

2.95

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

234

1.76

2.94

2.5

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

162

1236

1.32

2.92

1.5

1.4

278.06

265.42

ug/g

0.32

103

742

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.44

2.89

1.5

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

130

961

1.36

2.89

1.3

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1735

18436

0.90

2.83

4.8

5.8

2.80

3.55

ug/l

1.46

1547

16776

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

268

1.68

2.80

1.2

110.53

106.52

pmol/l

0.16

268

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

8.33

2.75

3.6

16.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3654

35622

1.13

2.74

5.6

5.0

4.30

4.65

mmol/l

81.29

3423

32755

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3628

35353

1.13

2.74

5.5

4.9

1.31

1.44

mmol/l

66.16

3381

32270

(40761539) Cells [Type] in Urine sediment by Light microscopy

104

2.12

2.73

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

263

1.68

2.71

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

517

1.48

2.71

1.3

0.20

0.31

nmol/l

0.52

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

638

5647

1.15

2.69

1.3

11.82

13.50

u/ml

0.24

239

2041

(3003327) Ova and parasites identified in Stool by Light microscopy

143

1088

1.32

2.66

1.5

1.7

—

(40768800) Prostate Pathology biopsy report

1355

0.72

2.62

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

456

1.50

2.61

1.2

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

4.00

2.56

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

260

1.66

2.56

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

255

1.65

2.47

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

310

1.59

2.45

1.7

1.3

1.19

1.22

promille

0.05

242

(3017704) Immunofixation for Urine

226

1.69

2.42

1.9

1.7

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.90

2.41

1.0

1.3

—

mmol/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

250

1.64

2.38

1.2

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.25

2.37

6.4

5.0

534.40

466.75

umol/l

—

(3049233) Organic acids panel - Urine

6.25

2.37

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.21

2.36

1.2

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.15

2.34

1.6

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

106

791

1.35

2.29

3.5

1.6

1.10

0.86

nmol/l

2.53

671

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

215

1.68

2.27

2.2

2.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.55

2.26

1.1

1.3

—

(3022145) Colonoscopy Study observation

517

4572

1.15

2.23

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

367

1.50

2.21

1.2

1.3

1.81

1.42

nmol/l

1.21

335

(3024263) Appearance of Synovial fluid

217

1.66

2.21

1.3

1.6

—

(3016750) Collection duration of Urine

202

1.69

2.20

2.2

2.0

484.81

481.11

min

0.07

141

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

266

1.58

2.13

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

266

1.58

2.13

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

129

1002

1.29

2.13

2.7

3.9

191.76

987.18

u/ml

1.65

116

929

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

503

1.42

2.12

2.2

1.9

36.16

25.29

mg/l

0.59

162

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

275

1.57

2.10

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1.58

2.08

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.26

2.07

1.1

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.50

2.05

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

269

1.57

2.04

1.2

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3906

38382

1.13

2.04

19.0

12.3

28.26

26.74

u/l

2.07

3824

37118

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

432

1.44

2.03

1.3

—

nmol/l

—

(3004775) Volume in Urine collected for unspecified duration

286

1.54

2.01

2.1

2.0

723.42

638.74

0.41

170

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.11

2.01

1.4

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

1.84

2.01

1.1

4.13

4.14

u/ml

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.50

2.00

1.5

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.50

2.00

1.5

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.50

2.00

1.5

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

163

1.72

1.97

1.9

2.1

32.00

112.47

ug/min

—

(36660697) Celiac disease serology panel - Serum

312

2684

1.17

1.97

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

186

1.67

1.96

2.0

1.7

38.46

40.32

g/l

1.00

186

(3019174) dRVVT (LA screen)

3.33

1.96

1.1

1.4

—

(3028433) Virus identified in Specimen by Culture

141

1.78

1.96

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.98

1.94

1.4

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

313

1.51

1.94

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.57

1.93

1.4

1.6

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.75

1.93

3.0

3.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

488

1.40

1.92

1.1

14.31

15.65

au/ml

—

114

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

106

1.89

1.90

1.2

10.51

8.50

pmol/l

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

291

1.52

1.88

1.3

31.87

27.00

u/l

0.39

239

(40768443) Skin Pathology biopsy report

215

1799

1.20

1.87

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

100

1.90

1.84

2.4

0.10

1.48

e9/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

1.70

1.84

1.3

1.7

2.68

9.89

nmol/l

1.25

135

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

109

1.84

1.76

1.5

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2895

29705

0.93

1.72

41.0

20.9

329.40

332.89

g/l

68.52

2882

29524

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3703

36350

1.10

1.72

6.3

5.7

2.51

2.74

mmol/l

52.49

3473

33268

(4038314) Semen analysis, post vasectomy

3.85

1.71

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

534

1.35

1.70

1.6

1.5

—

(3019150) Specific gravity of Urine by Refractometry

916

8505

1.10

1.69

4.8

4.0

1.02

1.20

kg/l

0.51

623

5717

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

226

1.55

1.69

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

164

1.65

1.67

1.1

1.3

54.29

488.61

ug/l

1.23

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

188

1.60

1.65

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

202

2380

0.84

1.65

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

228

1.54

1.64

1.4

1.2

10.36

9.58

mmol/l

0.39

214

(3004347) Hepatitis D virus Ab [Presence] in Serum

3.57

1.61

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.00

1.58

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

3.00

1.58

1.2

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.20

1.56

2.5

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.33

1.52

5.6

4.5

—

(3020650) Glucose [Presence] in Urine

143

0.42

1.51

1.2

1.8

0.50

0.04

estimate

—

143

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

374

1.39

1.51

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

332

1.42

1.51

1.9

1.6

23.25

29.26

u/ml

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

201

1.54

1.50

1.7

2.3

8.05

9.27

umol/l

0.21

139

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

234

1.50

1.48

2.7

1.8

119.33

101.70

ng/l

0.58

234

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

202

1.54

1.47

1.0

1.1

22.76

27.93

u/l

0.39

176

(3029396) Erythrocyte agglutination [Presence] in Blood

2.50

1.45

3.7

2.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

211

1.52

1.45

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

203

1.53

1.45

1.0

1.1

80.16

86.40

u/l

0.23

177

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.12

1.43

1.2

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.31

1.42

3.2

2.2

—

(44806420) Estimation of glomerular filtration rate

326

0.61

1.40

2.3

2.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.89

1.38

1.1

8.12

5.16

u/ml

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1104

10424

1.08

1.36

3.9

3.3

0.60

0.21

estimate

0.29

420

3231

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.61

1.36

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.61

1.36

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.94

1.35

1.4

1.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.94

1.35

2.0

1.6

—

(40768793) Breast Pathology biopsy report

707

1.26

1.34

1.3

1.4

—

(40757373) Influenza virus identified in Isolate

1.87

1.33

1.9

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

146

1731

0.84

1.33

3.0

3.8

496.95

1857.70

u/ml

1.09

130

1518

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.50

1.30

2.2

1.5

—

(3025130) Human papilloma virus identified in Specimen

268

1.42

1.27

1.8

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.40

1.24

2.5

1.8

0.67

umol/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

217

1893

1.15

1.24

1.2

99.50

118.55

u/ml

0.42

628

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

381

1.34

1.22

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

321

1.37

1.22

1.8

2.0

1.65

1.63

u/field

0.01

172

(3026389) Candida sp identified in Specimen by Organism specific culture

428

1.31

1.16

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

182

1.49

1.15

1.5

1.7

2.11

3.55

u/field

0.49

127

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

166

1.51

1.14

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.00

1.12

2.0

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

328

1.34

1.09

3.0

3.1

121.75

60.12

mg/l

0.48

254

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

294

1.36

1.09

1.4

1.3

1115.71

274.52

titre

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.73

1.08

1.1

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.73

1.08

2.0

—

(4024509) Urine culture

155

1789

0.86

1.07

2.4

2.0

—

(4015189) Microbial culture of sputum

105

1.62

1.05

1.4

2.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.79

1.04

1.1

1.2

50.31

47.81

mg/l

0.07

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

146

1.51

1.02

2.4

2.5

28.41

29.34

0.12

134

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.69

1.01

2.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.65

1.00

1.6

1.1

17.32

15.48

umol/l

1.06

(3036071) Salmonella sp Ab [Titer] in Serum

1.62

0.99

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

534

4969

1.08

0.99

5.1

4.9

31.53

31.78

0.21

394

3068

(40762887) Creatinine [Moles/volume] in Blood

2.17

0.98

1.2

1.6

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.97

0.0

1.4

—

0.50

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.95

0.0

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

110

934

1.18

0.94

1.6

1.5

12.74

8.07

u/l

2.10

740

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.61

0.93

1.1

1.2

16.13

37.16

—

(3034891) Synovial lining cells/cells in Synovial fluid

175

1.43

0.92

1.2

1.4

2.43

3.97

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.14

0.91

1.3

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

244

1.35

0.90

2.9

44.73

36.63

1.17

137

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

499

4653

1.08

0.89

3.8

4.7

9.40

25.80

ug/l

3.10

421

3880

(3001729) Color of Synovial fluid

2.07

0.89

1.2

1.5

—

(3017509) Phencyclidine [Presence] in Urine

2.07

0.89

2.0

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

290

3174

0.91

0.88

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

111

1.53

0.87

1.2

1.8

1.50

6.17

ug/l

0.99

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

593

1.22

0.87

1.1

180.60

1058.00

iu/ml

—

124

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

136

1.47

0.86

1.4

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

170

1.41

0.84

1.5

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.93

0.84

4.7

5.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

249

1.33

0.81

1.5

1.4

1.12

2.30

u/ml

0.77

156

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

220

1987

1.11

0.80

2.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

188

0.64

0.79

1.5

1.4

1.12

1.07

ratio

—

120

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

188

0.64

0.79

1.5

1.4

1.27

1.21

ratio

—

120

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

188

0.64

0.79

1.5

1.4

1.07

0.95

ratio

—

120

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.79

0.0

5.2

—

0.00

—

(3020393) Adenovirus Ag [Presence] in Stool

1.82

0.79

2.2

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

451

4813

0.93

0.79

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.67

0.78

6.5

7.1

8.61

8.60

mmol/l

0.00

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

187

0.64

0.78

1.5

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

9.44

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

394

1.25

0.76

1.1

2.47

2.13

eliau/ml

0.21

155

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.08

0.74

1.4

265.60

395.87

umol/24h

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.64

0.73

1.1

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.00

0.72

1.2

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.00

0.72

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.61

0.72

1.0

1.1

5.23

8.68

mg/g

—

(3011985) Renin [Units/volume] in Plasma

552

1.20

0.72

1.2

1.5

61.78

51.08

mu/l

0.24

491

(4212803) Bone marrow aspirate examination

1.75

0.71

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.92

0.70

2.0

2.6

—

(3028707) Methadone [Presence] in Urine by Screen method

409

1.22

0.68

2.1

3.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.85

0.68

3.0

5.9

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

178

1.35

0.68

2.1

3.3

1.94

1.29

0.48

178

(4094501) Cardiovascular stress test using bicycle ergometer

961

0.86

0.68

1.1

—

(3008295) Osmolality of Serum or Plasma

456

1.21

0.67

1.3

277.93

278.70

mosm/kgh2o

0.08

343

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.63

0.66

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

884

0.86

0.66

1.6

1.4

29.05

27.98

iu/l

0.09

742

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.59

0.65

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

471

0.80

0.65

1.1

0.19

1.32

u/ml

2.46

208

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

154

1.36

0.64

1.2

1.1

1034.19

1484.21

miu/ml

1.42

154

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.63

0.62

1.1

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

156

1.35

0.60

1.1

1.3

195.10

173.25

mmol/24h

0.41

156

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

0.19

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.25

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

105

1.43

0.59

3.0

3.8

10.13

9.19

mg/l

—

(40765096) Chromosome analysis panel by Banding

148

1.35

0.59

1.3

1.1

—

(3007461) Platelets [#/volume] in Blood

3970

39400

1.06

0.59

46.5

24.7

232.86

244.16

e9/l

21.52

3911

38455

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3971

39411

1.06

0.59

46.3

24.6

92.41

91.41

33.56

3942

38886

(3035941) MCH [Entitic mass]

3971

39411

1.06

0.59

46.2

24.6

30.47

30.48

0.13

3942

38886

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

114

1.40

0.58

1.1

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

201

1.29

0.58

6.1

7.1

17.21

267.33

ug/l

0.88

122

(3026361) Erythrocytes [#/volume] in Blood

3971

39413

1.06

0.58

46.4

24.6

4.41

4.51

e12/l

24.22

3908

38322

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3971

39413

1.06

0.58

49.0

25.1

40.22

40.82

2.76

3943

38862

(3050794) Legionella sp Ab [Presence] in Serum

1.71

0.57

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

511

1.18

0.57

1.2

1.4

268.78

290.95

pmol/l

0.22

435

(3010813) Leukocytes [#/volume] in Blood

3971

39418

1.06

0.56

46.5

24.7

7.20

6.76

e9/l

18.29

3914

38321

(3000963) Hemoglobin [Mass/volume] in Blood

3971

39420

1.06

0.56

46.9

24.8

133.19

136.46

g/l

27.93

3945

38911

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

160

0.69

0.55

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.62

0.55

1.0

1.1

106.67

87.35

titre

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

159

1.32

0.55

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

159

1450

1.10

0.54

1.2

1.1

80.00

125.12

titre

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

159

0.69

0.54

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.43

0.52

1.0

—

(4133840) Spirometry

0.61

0.52

1.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.50

0.51

1.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.47

0.50

1.4

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

156

0.70

0.50

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

1495

15272

0.97

0.50

2.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

0.82

0.49

1.2

1.1

4.53

2.27

u/ml

0.47

195

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

136

1240

1.10

0.48

1.5

1.6

34.55

17.97

u/ml

0.79

266

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.55

0.48

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

571

0.86

0.48

1.2

1.1

0.35

1.79

u/ml

5.16

318

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.52

0.48

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

199

1.26

0.47

1.5

1.4

9.96

8.50

ug/l

0.20

183

(3000330) Specific gravity of Urine by Test strip

180

1938

0.92

0.46

3.4

3.3

1.02

ratio

0.32

157

1766

(3023430) Cat dander IgE Ab [Units/volume] in Serum

364

0.82

0.46

1.1

2.32

4.00

u/ml

0.45

168

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

787

1.12

0.46

1.2

1.1

8.46

6.24

eliau/ml

0.24

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

291

1.20

0.46

1.6

1.7

475.20

304.93

mu/l

0.70

225

(3009466) Valproate [Moles/volume] in Serum or Plasma

617

1.14

0.46

5.6

5.4

351.25

354.03

umol/l

0.06

535

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

282

1.21

0.45

5.1

6.0

23.73

46.11

u/ml

1.40

(3025018) Bordetella pertussis Ab [Titer] in Serum

187

0.75

0.45

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

129

1.32

0.45

1.4

1.3

37.46

39.84

g/l

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

292

1.20

0.44

4.3

3.9

133.86

248.37

nmol/l

0.78

286

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

130

1.31

0.43

1.8

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

975

0.90

0.43

3.9

3.8

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.41

0.0

1.1

—

8.25

—

(40758358) Immune stain study

0.00

0.41

0.0

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

337

0.83

0.41

1.1

1.0

0.47

0.36

u/ml

0.12

128

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.39

0.40

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

336

0.83

0.40

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

227

0.79

0.40

1.7

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.40

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

408

1.15

0.39

1.3

1.2

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.10

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.37

0.38

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

523

1.13

0.38

1.4

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

483

0.87

0.38

1.0

1.1

3.55

4.17

u/ml

0.14

247

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

662

0.89

0.37

1.5

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

1071

10459

1.03

0.37

3.3

2.9

0.00

0.06

2.91

299

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

745

0.90

0.36

2.1

2.3

—

(40758292) HTLV I+II Ab panel - Serum

1.29

0.36

1.2

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

207

1.21

0.36

1.1

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.36

0.36

1.6

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

438

0.87

0.36

1.1

0.71

1.26

u/ml

0.44

227

(3006462) Nitrate [Presence] in Urine

162

1.23

0.35

4.0

3.7

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

108

1.30

0.35

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

108

1.30

0.35

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

108

1.30

0.35

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

108

1.30

0.35

1.0

1.1

—

(4198724) Urine methamphetamine measurement

126

1.27

0.35

1.9

3.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

393

0.86

0.34

1.1

—

3.05

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1534

15574

0.98

0.33

1.8

1.9

1.42

1.36

mmol/l

1.73

1266

12921

(4146454) Self-monitoring of blood glucose

464

1.12

0.32

2.3

2.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

185

0.81

0.30

2.4

1.5

26.21

27.92

umol/l

0.49

173

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

239

0.84

0.30

1.2

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

315

1.14

0.30

1.2

2.28

2.11

mmol/l

0.33

302

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

111

1.26

0.29

1.4

1.5

43.80

50.95

ug/l

0.36

111

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

174

0.80

0.29

1.0

1.1

126.17

289.18

ng/l

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.25

0.29

2.9

1.8

17.41

17.81

umol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.25

0.29

1.0

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.25

0.29

1.4

1.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.28

0.28

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

150

0.80

0.27

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

1.21

0.26

1.0

1.2

70.50

64.48

ug/l

—

(40768441) Liver Pathology biopsy report

290

1.14

0.26

1.5

1.4

—

(4211845) Urine protein measurement

179

1.17

0.24

3.9

3.5

—

(3023410) Appearance of Cerebral spinal fluid

390

0.90

0.23

1.6

1.7

—

(44806071) Cardiolipin IgM antibody measurement

1.25

0.22

1.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.25

0.22

1.0

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.25

0.22

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.0

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.22

0.22

1.4

1.2

18.46

25.27

nmol/l

—

(3044290) Cell count panel - Cerebral spinal fluid

802

0.93

0.21

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

843

0.94

0.21

1.5

202.03

861.66

e6/l

1.82

647

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

25.53

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.59

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.24

0.20

1.0

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.0

—

0.22

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.4

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.20

0.0

2.2

—

0.07

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.20

0.0

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

316

1.11

0.20

1.2

1.5

0.17

0.26

nmol/l

1.48

234

(1001926) Buprenorphine [Presence] in Urine by Screen method

741

1.07

0.20

2.3

2.5

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

250

0.88

0.20

1.1

1.20

7.98

nmol/l

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

0.81

0.20

1.6

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.20

0.19

1.0

1.1

—

(3008898) HLA-B27 [Presence]

103

976

1.06

0.19

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.21

0.19

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

127

1.18

0.19

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.15

0.19

1.0

1.2

—

(3028300) Cannabinoids [Presence] in Urine

948

0.95

0.18

2.5

2.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

204

1.13

0.17

1.1

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

1.12

0.17

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

152

0.85

0.17

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.76

0.17

5.2

3.1

24.60

43.82

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.76

0.17

10.4

6.2

7.40

8.15

—

(3027008) Opiates [Presence] in Urine

945

0.95

0.16

2.4

2.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

524

0.93

0.15

1.3

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

831

0.95

0.15

1.4

1.5

82.73

30.13

e6/l

0.31

598

(3027944) Amphetamines [Presence] in Urine

933

0.95

0.15

2.5

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

882

0.95

0.15

2.2

2.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

502

0.93

0.15

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.18

0.14

2.0

1.5

9.48

8.68

ug/l

0.22

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

118

0.85

0.14

1.1

3.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

1.11

0.13

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

886

0.96

0.13

2.5

2.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

814

0.96

0.12

5.8

3.4

27.62

29.29

mg/l

0.16

551

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

211

2160

0.97

0.12

1.8

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

231

2259

1.02

0.11

1.3

62.05

60.71

au/ml

—

165

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

188

0.90

0.11

1.2

1.1

0.90

1.18

u/l

—

(3024869) Neuronal Ab [Presence] in Serum

1.16

0.10

1.0

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

270

1.07

0.10

2.1

2.2

2.58

3.01

ug/l

0.33

249

(3000764) Benzodiazepines [Presence] in Urine

940

0.97

0.10

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

524

0.95

0.10

1.3

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.14

0.10

1.2

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.06

0.09

3.6

2.7

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.82

0.08

1.0

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

202

1982

1.02

0.08

1.7

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.08

0.08

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.12

0.07

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

347

0.95

0.07

1.5

1.8

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.07

0.07

1.4

1.7

—

79.76

—

(3033099) Centromere Ab [Titer] in Serum

0.84

0.07

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

234

0.94

0.06

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

178

1.07

0.05

1.1

—

(44813793) Dust mix specific IgE antibody measurement

198

1.06

0.05

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

262

0.95

0.05

2.3

2.2

1.91

1.89

ug/l

0.01

217

(3002256) Pathology report gross observation

547

5431

1.01

0.04

1.3

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

180

0.94

0.04

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

111

1.08

0.03

1.2

1.4

57.58

638.64

nmol/24h

1.39

111

(3011288) Drugs identified in Urine by Screen method Nominal

626

1.02

0.03

3.4

3.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

200

1.05

0.03

1.2

1.5

—

(3022621) pH of Urine by Test strip

298

2959

1.01

0.03

2.9

2.7

5.97

6.06

0.99

202

2027

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

248

2461

1.01

0.02

2.4

14.95

21.19

au/ml

0.46

235

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

143

1.05

0.01

1.0

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

183

1.04

0.01

1.2

0.53

0.56

ratio

0.19

107

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

366

0.98

0.00

1.1

1.2

8.97

7.44

mmol/l

1.50

323

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

214

1.03

0.00

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

138

1.01

0.00

1.3

1.2

9.00

11.12

mm/h

0.22

138

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

206

1.02

0.00

10.0

6.7

47.87

59.55

u/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

0.99

0.00

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

195

1.02

0.00

1.1

4.62

10.84

iu/ml

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

156

1.02

0.00

1.5

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

185

1.03

0.00

1.0

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

526

1.01

0.00

4.0

3.5

6.77

18.26

nmol/l

0.55

517

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.04

0.00

1.2

1.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

844

1.01

0.00

1.7

305.66

281.97

mu/l

0.27

792

(3035320) C reactive protein [Mass/volume] in Body fluid

270

1.00

0.00

2.2

2.7

31.38

32.40

mg/l

0.06

202

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

158

1579

1.00

0.00

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

106

1.04

0.00

1.0

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

126

1.03

0.00

1.0

1.1

0.11

3.39

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

49.25

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1493.75

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.98

-0.00

1.2

1.3

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

235.00

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

413.86

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.89

-0.00

1.2

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

20.02

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.98

-0.00

1.0

26.94

44.61

iu/ml

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1487.00

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.4

—

0.21

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: I9_NONISCHCARDMYOP_STRICT – Nonischemic cardiomyopathy

GWS hits: 10

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Nonischemic cardiomyopathy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Nonischemic cardiomyopathy (I9_NONISCHCARDMYOP_STRICT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints